TWI304442B - Expression system for producing collagen - Google Patents

Expression system for producing collagen Download PDF

Info

Publication number
TWI304442B
TWI304442B TW94141441A TW94141441A TWI304442B TW I304442 B TWI304442 B TW I304442B TW 94141441 A TW94141441 A TW 94141441A TW 94141441 A TW94141441 A TW 94141441A TW I304442 B TWI304442 B TW I304442B
Authority
TW
Taiwan
Prior art keywords
collagen
recombinant
cell
hydroxylase
proline
Prior art date
Application number
TW94141441A
Other languages
Chinese (zh)
Inventor
Min Yuan Chou
Hsiu Chuan Li
Chuan Chuan Huang
Original Assignee
Ind Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Tech Res Inst filed Critical Ind Tech Res Inst
Priority to TW94141441A priority Critical patent/TWI304442B/en
Application granted granted Critical
Publication of TWI304442B publication Critical patent/TWI304442B/en

Links

Description

13044421304442

A L 九、發明說明: 【發明所屬之技術領域】 本發明係有關於生產膠原蛋白之表現系統,更特別地,係 關於穩定轉染昆蟲細胞株以同時表現重組膠原蛋白與脯胺酸4-經化酶(prolyl 4-hydroxylase)。 【先前技術】AL IX. DESCRIPTION OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to a system for producing collagen, and more particularly to a stable transfected insect cell line for simultaneously expressing recombinant collagen and proline 4- Prolyl 4-hydroxylase. [Prior Art]

膠原蛋白屬於胞外基質蛋白,含有Gly-X-Y三胺基酸重複 序列’且此三胺基酸重複序列允許三個膠原蛋白多胜狀鍵(α-鍵) 摺疊成三螺旋結構。上述Gly-X-Y三胺基酸重複序列中的Υ位 置通常為脯胺酸(proline),且脯胺酸可在膠原蛋白多胜肽鏈進行 轉譯後修飾時發生4·羥化而可穩定膠原蛋白的三螺旋結構。若 是沒有進行脯胺酸羥化反應,膠原蛋白主要的三螺旋結構就會 在低於生理活性溫度時變得不穩定(Berg,R. A·以及Prockop,D· J. (1973) Biochem Biophys Res Commun 52,115-120; Rosenbloom,J·,等人(1973) Arch Biochem Biophys 158, 478-484)。脯胺酸4-羥化酶(EC 1.14_11_2)是催化所有膠原蛋白 的脯胺酸殘基進行4-羥化的關鍵,脊椎動物來源的脯胺酸4-羥 化酶為α2β2四元體,包括兩個不同的次單位(Kivirikko, K. I·,等 人(1989) Faseb J3,1609-1617)。α次單位包括催化及與胜肽-受 質結合區間(catalytic and peptide-substrate binding domains),但 若沒有β次單位協助就不會活化。β次單位經發現等同於蛋白質-雙硫鍵異構酶(protein-disulfide isomerase)(Koivu,J·,等人(1987) J Biol Chem 262,6447-6449;以及 Pihlajaniemi,T·,等人(1987) Embo J6, 643-649)。在膠原蛋白生合成的過程中,前膠原蛋白α 鏈會共轉譯地移轉到内質網内腔,在此經脯胺酸4-羥化酶進行 0648-A20623TWF(N2);P13930006; chiumeow 5 1304442 羥化反應。脯胺酸4-羥化酶需要Fe2+,2-酮戊二酸 (2-oxoglutarate),02與抗壞血酸,以及脊椎動物細胞之活化系 統,方可將2-酮戊二酸與抗壞血酸移轉到内質網的内腔 (Kivirikko, Κ· I.,等人(1989) Faseb J3, 1609-1617)。目前已成功 地在活體外表現活化的重組脯胺酸4-羥化酶,例如以重組桿狀 病毒將脯胺酸4-羥化酶次單位共同感染昆蟲細胞如秋黏蟲 (Spodoptera frugiperda)與擬 K 竣(Trichoplusia ni)(y\xoici,K·,等 人(1992) Proc Natl Acad Sci USA 89, 7467-7470),或者以表現載 體共轉染哺乳類細胞株如COS-1 (John,D. C.,&Bulleid,N.J. (1996) Biochem J 317 (Pt 3),659-665)及 HEK293 (Wagner,K·,等 人(2000) Biochem J352 Pt 3,907-911),或酵母菌如甲醇酵母 /^Wc^zsXVuorela,A.,等人(1997) Embo J16,6702-6712) 及釀酒酵母似)(Toman,P. D·,等人(2000) J Biol Chem 275, 23303-23309)。 目前生產重組膠原蛋白之表現系統包括大腸桿菌(五. co/〇,酵母菌,哺乳動物細胞株,昆蟲細胞株,及轉殖基因動 物以及植物,然而,這些表現系統皆有其缺陷。例如,大腸桿 菌表現系統沒有轉譯後修飾,而酵母菌表現系統缺乏脯胺酸4-羥化酶活性,然而甲醇酵母中的膠原蛋白產量卻又是這些表現 系統中最高的。哺乳動物細胞株之表現系統產量低且受限於特 定細胞類型,而昆蟲細胞之表現系統中脯胺酸4-羥化酶活性又 低。若論及轉殖基因動物,如蠶或小鼠,或轉殖基因植物,如 菸草,其膠原蛋白產物則會過度交聯。 目前已建立一含有編碼人類脯胺酸4-羥化酶以及膠原蛋白 之基因的桿狀病毒表現系統(美國專利第5,077,214號以及第 5,593,859號),然而,經轉染的昆蟲細胞在72小時内會死亡, 0648-A20623TWF(N2);P13930006; chiumeow 6 1304442 造成僅有暫時性的重組蛋白生產。此外,由於胞溶作用,將很 難回收或純化重組膠原蛋白。而且,膠原蛋白為分泌型或膜蛋 白質,而桿狀病毒對於内質網或高基氏體的破壞更限制了膠原 蛋白的生產。 因此,仍需尋求以高產量生產具有生物活性之膠原蛋白的 , 表現系統。 【發明内容】 本發明内容係關於一種重組昆蟲細胞,特別地,一種穩定 • 表現人類脯胺酸4-羥化酶(Ρ4Η)之重組昆蟲細胞。其中,該 重組昆蟲細胞為擬尺蠖叫以及果蠅⑺叩⑹“ melanogaster S2) 〇 本發明之另一内容係關於一種生產重組膠原蛋白的方法, 特別地,該方法包含提供一包含一經轉染之編碼脯胺酸‘羥化 酶之基因之重組昆蟲細胞,以及轉染一包含重組膠原蛋白基因 之表現載體至前述該重組昆蟲細胞的步驟。 本發明之又一内容係關於一種生產重組膠原蛋白的方法, • 特別地,該方法包含提供一包含一經轉染之編碼重組膠原蛋白 基因及編碼脯胺酸4-羥化酶基因之重組昆蟲細胞的步驟。 因此,本發明之一實施型態提供一種重組昆蟲細胞。上述 重組細胞包括一經轉染之編碼人類脯胺酸4_羥化酶的基因。上 述脯胺酸4-羥化酶基因係包括序列識別號·· 3、5或其組合的核 苷酸序列。上述重組細胞更包括一 DNA分子,其包括序列識別 號:1的核苷酸序列。上述DNA分子編碼第XXI型膠原蛋白之 膠原蛋白三螺旋(COL1)區間以及c端非膠原蛋白(NC1)區間。 上述細胞可為擬尺蠖(7WM吵/⑽以則·)細胞或果蠅 0648-A20623TWF(N2);P13930006; chiumeow 7Collagen belongs to the extracellular matrix protein and contains the Gly-X-Y triamino acid repeat sequence' and this triamino acid repeat allows the folding of the three collagen poly-success bonds (α-bonds) into a triple helix. The guanidine position in the above Gly-XY tribasic acid repeat is usually proline, and the proline can be hydroxylated to stabilize the collagen when the collagen polypeptide chain is post-translationally modified. The triple helix structure. If the hydroxylation of proline is not carried out, the main triple helix of collagen will become unstable at physiologically lower temperatures (Berg, R. A. and Prockop, D. J. (1973) Biochem Biophys Res Commun 52, 115-120; Rosenbloom, J., et al. (1973) Arch Biochem Biophys 158, 478-484). Proline 4-hydroxylase (EC 1.14_11_2) is the key to catalyze the 4-hydroxylation of all collagen's proline residues. The vertebrate-derived proline 4-hydroxylase is α2β2 quaternary. Includes two different subunits (Kivirikko, K. I., et al. (1989) Faseb J3, 1609-1617). The alpha subunits include catalytic and peptide-substrate binding domains, but will not be activated without beta subunit assistance. The beta subunit was found to be equivalent to the protein-disulfide isomerase (Koivu, J., et al. (1987) J Biol Chem 262, 6447-6449; and Pihlajaniemi, T., et al. 1987) Embo J6, 643-649). During collagen biosynthesis, the procollagen alpha chain is transferred to the lumen of the endoplasmic reticulum, where it is subjected to lysine 4-hydroxylase 0648-A20623TWF(N2); P13930006; chiumeow 5 1304442 Hydroxylation reaction. Proline 4-hydroxylase requires Fe2+, 2-oxoglutarate, 02 and ascorbic acid, and activation systems for vertebrate cells to transfer 2-ketoglutarate and ascorbic acid The lumen of the quality net (Kivirikko, Κ·I., et al. (1989) Faseb J3, 1609-1617). Activated recombinant proline 4-hydroxylase has been successfully demonstrated in vitro, for example, by recombinant baculovirus, a pro-acid 4-hydroxylase subunit is co-infected with insect cells such as Spodoptera frugiperda and Trichoplusia ni (y\xoici, K., et al. (1992) Proc Natl Acad Sci USA 89, 7467-7470), or co-transfection of mammalian cell lines such as COS-1 (John, DC) with expression vectors. , &Bulleid, NJ (1996) Biochem J 317 (Pt 3), 659-665) and HEK293 (Wagner, K., et al. (2000) Biochem J352 Pt 3, 907-911), or yeast such as methanol yeast /^Wc^zsXVuorela, A., et al. (1997) Embo J16, 6702-6712) and Saccharomyces cerevisiae (Toman, P. D., et al. (2000) J Biol Chem 275, 23303-23309). Currently, the expression systems for producing recombinant collagen include Escherichia coli (five co., yeast, mammalian cell strain, insect cell strain, and transgenic animal and plant), however, these expression systems have their defects. For example, The E. coli expression system has no post-translational modification, while the yeast expression system lacks proline 4-hydroxylase activity, whereas collagen production in methanol yeast is the highest in these performance systems. The yield is low and limited by the specific cell type, while the activity of the proline acid 4-hydroxylase in the insect cell expression system is low. If it is referred to the transgenic animal, such as silkworm or mouse, or the transgenic plant, such as In tobacco, the collagen product is excessively cross-linked. A baculovirus expression system containing a gene encoding human pro-acid 4-hydroxylase and collagen has been established (U.S. Patent Nos. 5,077,214 and 5,593,859). However, transfected insect cells die within 72 hours, 0648-A20623TWF (N2); P13930006; chiumeow 6 1304442 causes only temporary Recombinant protein production. In addition, it is difficult to recover or purify recombinant collagen due to cytolysis. Moreover, collagen is a secreted or membrane protein, and baculovirus damages endoplasmic reticulum or high-ketite. Production of proteins. Therefore, there is still a need to find a system for producing bioactive collagen in high yield. SUMMARY OF THE INVENTION The present invention relates to a recombinant insect cell, in particular, a stable • performance of human proline 4 - a recombinant insect cell of hydroxylase (Ρ4Η), wherein the recombinant insect cell is a pseudo-squeak and a fruit fly (7) 叩 (6) "melanogaster S2" 另一 another aspect of the invention relates to a method for producing recombinant collagen, in particular The method comprises the steps of providing a recombinant insect cell comprising a transfected gene encoding a proline acid 'hydroxylase, and transfecting a expression vector comprising the recombinant collagen gene into the recombinant insect cell. Yet another aspect relates to a method of producing recombinant collagen, and, in particular, the method comprises A step comprising a transfected recombinant insect gene encoding a recombinant collagen gene and a gene encoding a proline 4-hydroxylase gene. Accordingly, one embodiment of the present invention provides a recombinant insect cell. Transfected gene encoding human proline 4_hydroxylase. The above-described proline 4-hydroxylase gene sequence includes the nucleotide sequence of sequence identification number, 3. 5, or a combination thereof. A DNA molecule comprising a nucleotide sequence of SEQ ID NO: 1. The DNA molecule encodes a collagen triple helix (COL1) region of type XXI collagen and a c-terminal non-collagen protein (NC1) region.蠖 蠖 (7WM noisy / (10) with · ·) cells or fruit flies 0648-A20623TWF (N2); P13930006; chiumeow 7

13044.42 melanogaster)^ ° 本發明之另一實施型態提供一種生產重組膠原蛋白之方 法。上述方法包括以下步驟:提供一重組昆蟲細胞,其包括一 經轉染之編碼人類脯胺酸4-羥化酶之基因;將一表現載體轉染 至上述細胞,上述表現載體包括一重組膠原蛋白基因;於適於 上述重組膠原蛋白基因表現之條件下培養上述細胞;以及回收 經表現之重組膠原蛋白。上述脯胺酸4-羥化酶基因係包括序列 識別號:3、5或其組合的核苷酸序列。此外,上述細胞可為擬 獲(Trichoplusia ni)細胞或象織(Drosophila melanogaster)細 胞。 本發明之又一實施型態提供一種生產重組膠原蛋白之方 法。上述方法包括以下步驟··提供一重組昆蟲細胞,其包括一 經轉染之編碼重組膠原蛋白之基因,以及一經轉染之編碼脯胺 酸4_羥化酶之基因;於適於上述重組膠原蛋白表現之條件下培 養上述重組昆蟲細胞;以及回收經表現之重組膠原蛋白。上述 脯胺酸4-羥化酶基因係包括序列識別號:3、5或其組合的核苷 酸序列。此外,上述細胞可為擬尺螻π/)細胞或果 規(Drosophila melanogaster)細胞0 本發明之再一實施型態提供一種DNA分子,其包括序列識 別號:1之核苷酸序列。上述DNA分子編碼第XXI型膠原蛋白 之膠原蛋白三螺旋(C0L1)區間以及C端非膠原蛋白(NC1)區 間。同時提供編碼上述DNA分子之重組膠原蛋白。 【實施方式】 本發明提供一種重組膠原蛋白以及其對應之DNA分子,一 種包括經轉染編碼人類脯胺酸羥化酶之基因的重組昆蟲細胞, 0648-A20623TWF(N2);P13930006; chiumeow 8 (Q、<1办13044.42 melanogaster) ^ ° Another embodiment of the invention provides a method of producing recombinant collagen. The above method comprises the steps of: providing a recombinant insect cell comprising a transfected gene encoding human proic acid 4-hydroxylase; transfecting a expression vector into said cell, said expression vector comprising a recombinant collagen gene The cells are cultured under conditions suitable for the expression of the recombinant collagen gene described above; and the expressed recombinant collagen is recovered. The above proline 4-hydroxylase gene line includes the nucleotide sequence of the sequence identification number: 3, 5 or a combination thereof. Further, the above cells may be Trichoplusia ni cells or Drosophila melanogaster cells. Yet another embodiment of the present invention provides a method of producing recombinant collagen. The above method comprises the steps of: providing a recombinant insect cell comprising a transfected gene encoding recombinant collagen, and a transfected gene encoding a proline 4_hydroxylase; suitable for the above recombinant collagen The above recombinant insect cells are cultured under the conditions of performance; and the expressed recombinant collagen is recovered. The above proline 4-hydroxylase gene line includes a nucleotide sequence of SEQ ID NO: 3, 5 or a combination thereof. Further, the above-mentioned cells may be Drosophila melanogaster cells or a further embodiment of the present invention. A DNA molecule comprising the nucleotide sequence of Sequence Identification No. 1: The above DNA molecule encodes a collagen triple helix (C0L1) region of the XXI type collagen and a C-terminal non-collagen protein (NC1) region. A recombinant collagen encoding the above DNA molecule is also provided. [Embodiment] The present invention provides a recombinant collagen and a corresponding DNA molecule thereof, comprising a recombinant insect cell transfected with a gene encoding human prolamine hydroxylase, 0648-A20623TWF(N2); P13930006; chiumeow 8 ( Q, <1

1304442 以及一種使用上述重組昆蟲細胞生產重組膠原蛋白之方法。 因此,本發明之一實施型態係提供一種重組昆蟲細胞,其 包括一經轉染之編碼脯胺酸4-羥化酶的基因。上述經轉染之基 因包括脯胺酸4-經化酶之α次單位以及/或β次單位。脯胺酸4-羥化酶之α次單位包括序列識別號:3之核苷酸序列,而脯胺酸 4-羥化酶之β次單位包括序列識別號:5之核苷酸序列。上述重 組昆蟲細胞更包括另一經轉染之基因,其編碼第XXI型膠原蛋 白之膠原蛋白三螺旋(COL1)區間以及C端非膠原蛋白(NC1)區 間,包括序列識別號:1之核苷酸序列。 於本發明之重組昆蟲細胞實施例中,上述細胞可為擬尺蠖 (Trichoplusia ni)細胞氣果織(Drosophila melanogaster)細胞,較 佳為果蠅me/α⑽細胞。上述經轉染脯胺酸4_ 羥化酶與編碼第XXI型膠原蛋白之膠原蛋白三螺旋(COL1)區間 以及C端非膠原蛋白(NC1)區間之果蠅細胞(命名為 DS2/p4H/mC21)已於中華民國94年9月6曰寄存於財團法人食 品工業發展研究所,編號為BCRC 960245。 本發明之另一實施型態提供一種生產重組膠原蛋白之方 法。上述方法包括以下步驟:提供一重組昆蟲細胞;將一表現 載體轉染至上述細胞中,其中上述表現載體包括一重組膠原蛋 白基因;於適於上述重組膠原蛋白基因表現之條件下培養上述 細胞;以及回收經表現之重組膠原蛋白。 於本發明之生產重組膠原蛋白之方法的實施例中,上述重 組昆蟲細胞包括一經轉染之編碼人類脯胺酸4-羥化酶的基因。 特別是,上述經轉染之編碼人類脯胺酸4-羥化酶的基因包括脯 胺酸4-羥化酶之α次單位以及/或β次單位。上述脯胺酸4_羥化 酶之α次單位包括序列識別號:3之核苷酸序列,而上述脯胺酸 0648-A20623TWF(N2);P13930006; chiumeow 91304442 and a method of producing recombinant collagen using the above recombinant insect cells. Accordingly, one embodiment of the present invention provides a recombinant insect cell comprising a transfected gene encoding a proline 4-hydroxylase. The above transfected genes include alpha subunits and/or beta subunits of proline 4-transferase. The alpha subunit of proline 4-hydroxylase includes the nucleotide sequence of SEQ ID NO: 3, and the β subunit of proline 4-hydroxylase includes the nucleotide sequence of SEQ ID NO: 5. The above recombinant insect cell further comprises another transfected gene encoding the collagen triple helix (COL1) region of the XXI type collagen and the C-terminal non-collagen protein (NC1) region, including the nucleotide of the sequence identifier: sequence. In the embodiment of the recombinant insect cell of the present invention, the above cell may be a Trichoplusia ni cell Drosophila melanogaster cell, preferably a Drosophila me/α (10) cell. The above transfected proline 4_hydroxylase and the collagen triple helix (COL1) region encoding the XXI collagen and the C-terminal non-collagen (NC1) region of the Drosophila cell (designated DS2/p4H/mC21) It was deposited in the Food Industry Development Research Institute of the People's Republic of China on September 6, 1994, under the number BCRC 960245. Another embodiment of the invention provides a method of producing recombinant collagen. The method comprises the steps of: providing a recombinant insect cell; transfecting a expression vector into the cell, wherein the expression vector comprises a recombinant collagen gene; and cultivating the cell under conditions suitable for the expression of the recombinant collagen gene; And recovering the expressed recombinant collagen. In an embodiment of the method of producing a recombinant collagen of the present invention, the above recombinant insect cell comprises a transfected gene encoding human proline 4-hydroxylase. In particular, the above transfected gene encoding human proline 4-hydroxylase includes alpha units and/or beta units of niamin 4-hydroxylase. The alpha subunit of the above proline 4_hydroxylase comprises the nucleotide sequence of SEQ ID NO: 3, and the above proline is 0648-A20623TWF(N2); P13930006; chiumeow 9

<7<7

13044,42 4-羥化酶之β次單位包括序列識別號:5之核苷酸序列。上述重 組細胞可為擬尺墣m·)細胞或果繩 melanogaster)^ 〇 於本發明之生產重組膠原蛋白之方法的另一實施例中,上 述重組膠原蛋白基因係編碼第XXI型膠原蛋白之膠原蛋白三螺 旋(COL1)區間以及C端非膠原蛋白(NC1)區間,包括序列識別 號:1之核苷酸序列。上述經表現之重組膠原蛋白係經分泌的。 本發明之又一實施型態係提供一種生產重組膠原蛋白之方 法。上述方法包括以下步驟:提供一重組昆蟲細胞,其包括一 經轉染之編碼重組膠原蛋白的基因,以及一經轉染之編碼脯胺 酸4-羥化酶的基因;於適於重組膠原蛋白表現之條件下培養上 述重組昆蟲細胞;以及回收經表現之重組膠原蛋白。 於本發明之生產重組膠原蛋白之方法的實施例中,上述重 組膠原蛋白基因係編碼第XXI型膠原蛋白之膠原蛋白三螺旋 (COL1)區間以及C端非膠原蛋白(NC1)區間,包括序列識別號: 1之核苷酸序列。上述經表現的重組膠原蛋白係經分泌的。 於本發明之生產重組膠原蛋白之方法的另一實施例中,上 述經轉染之編碼脯胺酸4-羥化酶的基因包括脯胺酸4-羥化酶之 α次單位以及/或β次單位。上述脯胺酸4-羥化酶之α次單位包括 序列識別號:3之核苷酸序列,以及述脯胺酸4-羥化酶之β次單 位包括序列識別號:5之核苷酸序列。 於本發明之生產重組膠原蛋白之方法的又一實施例中,上 述昆蟲細胞可為擬尺蠖/Π·)細胞或果绳 細胞,較佳地為果繩細 胞。 本發明之再一實施型態提供一種DNA分子,其包括序列識 0648-A20623TWF(N2);P13930006; chiumeow 1013044, 42 The β-unit of 4-hydroxylase includes the nucleotide sequence of SEQ ID NO: 5. In the other embodiment of the method for producing recombinant collagen of the present invention, the recombinant cell may encode collagen of type XXI collagen. The protein triple helix (COL1) region and the C-terminal non-collagen protein (NC1) region include the nucleotide sequence of SEQ ID NO: 1. The above expressed recombinant collagen is secreted. Yet another embodiment of the present invention provides a method of producing recombinant collagen. The above method comprises the steps of: providing a recombinant insect cell comprising a transfected gene encoding recombinant collagen, and a transfected gene encoding a proline 4-hydroxylase; suitable for recombinant collagen expression The above recombinant insect cells are cultured under the conditions; and the expressed recombinant collagen is recovered. In the embodiment of the method for producing recombinant collagen of the present invention, the recombinant collagen gene line encodes a collagen triple helix (COL1) region of the XXI type collagen and a C-terminal non-collagen protein (NC1) region, including sequence recognition. No.: 1 nucleotide sequence. The above expressed recombinant collagen is secreted. In another embodiment of the method of producing a recombinant collagen of the present invention, the transfected gene encoding a proline 4-hydroxylase comprises an alpha unit of a proline 4-hydroxylase and/or a beta Subunit. The α-subunit of the above proline 4-hydroxylase includes the nucleotide sequence of SEQ ID NO: 3, and the β-unit of the pro-acid 4-hydroxylase includes the nucleotide sequence of SEQ ID NO: 5 . In still another embodiment of the method of producing a recombinant collagen of the present invention, the above insect cells may be cells of the genus 或/蠖·) or fruit rope cells, preferably fruit rope cells. A further embodiment of the invention provides a DNA molecule comprising sequence recognition 0648-A20623TWF(N2); P13930006; chiumeow 10

1304442 » i 別號:1之核苷酸序列。上述DNA分子係編碼第XXI型膠原蛋 白之膠原蛋白三螺旋(COL1)區間以及C端非膠原蛋白(NC1)區 間。同時提供一種由上述DNA分子所編碼之重組膠原蛋白。 採用桿狀病毒感染系統,在鱗翅類昆蟲細胞,包括秋黏蟲 (Spodoptera frugiperda)以反擬 K 獲(Trichoplusia ni),共两表現 膠原蛋白基因以及編碼脯胺酸4-羥化酶之二個次單位,已可獲 得完全羥化且熱穩定之膠原蛋白(Lamberg,A·,等人(1996) J Biol Chem 271,11988-11995; Hagg,Ρ· M·,等人(1997) Am J Pathol 150, 2075-2086; Myllyharju,J·,等人(1997) J Biol Chem 272, 21824-21830; Nokelainen,M·,等人(1998) Matrix Biol 16, 329-338; Pihlajamaa,T·,等人(1999) J Biol Chem 274, 22464_22468)。然而,桿狀病毒系統之缺點之一是細胞最後會被 所感染的病毒破壞,造成僅有暫時性的重組蛋白質生產。於本 發明中,建立了非胞溶之昆蟲表現系統,包括擬尺蠖 (7Wc/^p/謂以)以及果蠅(Drosophh S2)細胞,以促進重組膠原 蛋白生產之下游過程。由於脯胺酸4-羥化酶是膠原蛋白生合成 的關鍵性酵素,在這些穩定轉染昆蟲細胞系統中有高表現量的 功能性脯胺酸4-羥化酶,能確保膠原蛋白鏈後來能成功地進行 二元體組合。在果蠅S2)誘導系統中共同表現之 P4Hcx與Ρ4Ηβ次單位’以及脯胺酸4-羥化酶之總活性會比擬尺 蠖(he 則)系統咼3〜4倍以上,這可能是由於插入果 蠅S2)細胞之基因體的重組質體載體複製數(c〇py number)比較高的因素。2-酮戊二酸(2_〇x〇glutamte)酵素試驗確 涊了經穩定轉染之果蠅印S2)系統可以產出功能性重 組P4H。後續mC21(小型第XX!型膠原蛋白)三元體組合結果更 證明了對於膠原蛋白鏈之脯胺酸羥化以及穩定三螺旋結構而 0648_A20623TWF(N2);P13930006; chiumeow1304442 » i nickname: nucleotide sequence of 1. The above DNA molecule encodes the collagen triple helix (COL1) region of the XXI-type collagen protein and the C-terminal non-collagen protein (NC1) region. Also provided is a recombinant collagen encoded by the above DNA molecule. Using the baculovirus infection system, the lepidopteran insect cells, including the Spodoptera frugiperda, were obtained by Trichoplusia ni, which showed two collagen genes and two times encoding proline 4-hydroxylase. In this unit, fully hydroxylated and thermostable collagen has been obtained (Lamberg, A., et al. (1996) J Biol Chem 271, 11988-11995; Hagg, Ρ·M·, et al. (1997) Am J Pathol 150 , 2075-2086; Myllyharju, J., et al. (1997) J Biol Chem 272, 21824-21830; Nokelainen, M., et al. (1998) Matrix Biol 16, 329-338; Pihlajamaa, T., et al. 1999) J Biol Chem 274, 22464_22468). However, one of the disadvantages of the baculovirus system is that the cells are eventually destroyed by the infected virus, resulting in only transient recombinant protein production. In the present invention, non-cytosolic insect expression systems have been established, including the pseudo-scale (7Wc/^p/) and Drosophh S2 cells to promote the downstream process of recombinant collagen production. Since proline 4-hydroxylase is a key enzyme in collagen biosynthesis, there is a high amount of functional proline 4-hydroxylase in these stable transfected insect cell systems, ensuring collagen chains later The binary combination can be successfully performed. The total activity of P4Hcx and Ρ4Ηβ subunits and proline 4-hydroxylase in the Drosophila S2) induction system is more than 3 to 4 times higher than that of the 蠖 蠖 (he) system, which may be due to the insertion of fruit. The recombinant plasmid vector (c〇py number) of the gene of the fly S2) cell is relatively high. The 2-ketoglutamate (2_〇x〇glutamte) enzyme test confirmed that the stable transfection of the fruit fly S2) system could produce a functional recombination of P4H. Subsequent mC21 (small XX! collagen) ternary combination results further demonstrated hydroxylation of the proline in the collagen chain and stable triple helix structure. 0648_A20623TWF(N2); P13930006; chiumeow

1304442 言,P4H的確具有功能上的活性。這些結果暗示了 ρ4Ηα以及 Ρ4Ηβ可在果蠅(乃⑽叩表現系統中組合成為活化的α2β2四 元體。 本發明係首次於果罐(Dros印办似如)細胞中採用 三基因表現系統生產重組膠原蛋白。此外,本發明實施例之結 果也為首次提供重組人類第XXI型小型膠原蛋白分子之三螺旋 形成的生化證明,且證明其於果蠅(乃^^吵/^/β S2)細胞中僅在足 夠量之活化的脯胺酸4 -羥化酶存在下方可形成雙硫鍵結之聚合 物。基於質譜分析結果,發現即使與P4H共同表現,mC21中 仍存有相當量之未羥化脯胺酸殘基。由於果蠅(Dr似吵/π·/α S2) 細胞不能在低於 2 X 105 細胞 s/ml (Echalier,G. (1997) cells in culture,Chapters 2 and 3, Academic Press,New York)之 細胞密度下生存,很難選擇同時含有mC21,Ρ4Ηα以及Ρ4Ηβ 三基因表現構築體的單一穩定株。因此,所建立的穩定轉染多 株細胞族群,可能包括除了抗生素選擇載體外,僅有mC21構 築體的細胞。因此,由P4H共同表現之穩定果蠅S2) 細胞中所純化的mC21才會包括未羥化的膠原蛋白分子。抗胃 蛋白酶,非鏈間雙硫鍵結之mC21三螺旋結構的存在代表了第 XXI型膠原蛋白之三元體組合可能係由COL1區間以及 COL1/NC1區間之接界的兩半胱胺酸之雙硫橋間起始,且其並非 三螺旋結構形成之必要條件。這樣的結果與之前研究發現採用 桿狀病毒表現系統時,重組小型第XII型膠原蛋白之組合會顯 示出三螺旋COL1區間的摺疊早於雙硫鍵形成是一致的 (Mazzorana,M·,等人(2001) J Biol Chem 276, 27989_27998)。 本發明實施例之結果顯示小型第XXI型膠原蛋白之三元體的鏈 間雙硫鍵形成係依存於膠原蛋白鏈的羥化脯胺酸量,暗示了三 0648-A20623TWF(N2);P13930006; chiumeow 12 1304442 螺旋結構的組合控制了鏈間雙硫橋的形成。1304442 Words, P4H does have functional activity. These results suggest that ρ4Ηα and Ρ4Ηβ can be combined into an activated α2β2 quaternary body in the Drosophila (the (10) 叩 expression system. The present invention is the first to use the three gene expression system to produce recombination in a fruit can (Dros print-like) cell. In addition, the results of the examples of the present invention are also the first biochemical proof of the triple helix formation of recombinant human type XXI small collagen molecules, and proved to be in Drosophila melanogaster (Nai ^ ^ / / / S 2) cells The disulfide-bonded polymer can be formed only in the presence of a sufficient amount of activated proline 4-hydroxylase. Based on the results of mass spectrometry analysis, it was found that even in the presence of P4H, there is still a considerable amount of unoxygenated in mC21. Lysine residues. Since Drosophila (Dr like noisy/π·/α S2) cells cannot be below 2 X 105 cells s/ml (Echalier, G. (1997) cells in culture, Chapters 2 and 3, Academic Press, New York) Survival at cell density, it is difficult to select a single stable strain containing both mC21, Ρ4Ηα and Ρ4Ηβ three gene expression constructs. Therefore, the establishment of stable transfection of multiple cell populations may include Carriers for antibiotic selection, only cells mC21 building body structure. Therefore, the performance of common P4H stable Drosophila S2) cells as purified mC21 will not include hydroxylation of collagen molecules. The presence of anti-pepsin, a non-stranded disulfide-bonded mC21 triple helix structure, indicates that the ternary combination of type XXI collagen may be bound by the COL1 interval and the COL1/NC1 interval. It starts between the disulfide bridges and is not a necessary condition for the formation of a triple helix structure. This result is consistent with previous studies showing that the combination of recombinant small type XII collagen showed that the fold of the triple helix COL1 interval was earlier than the formation of disulfide bonds when using the baculovirus expression system (Mazzorana, M., et al. (2001) J Biol Chem 276, 27989_27998). The results of the examples of the present invention show that the interchain disulfide bond formation of the small XXI type collagen ternary is dependent on the amount of hydroxylated guanamine of the collagen chain, suggesting that 3648-A20623TWF(N2); P13930006; Chiumeow 12 1304442 The combination of helical structures controls the formation of interchain bisulfur bridges.

本發明人證明了在果蠅S2)細胞表現系統中生 產活化的重組人類脯胺酸4-羥化酶以及具有穩定三螺旋結構之 膠原蛋白分子的可能性。此外,此等非胞溶性昆蟲細胞系統也 提供了研究膠原蛋白三螺旋結構組合相關機制一條方便之路, 特別是針對在細胞與組織表現量過低的膠原蛋白,將便於進行 蛋白質層次的研究。同時,發現p4H與mC21可以在果蠅 S2)細胞株穩定表現,代表了果蠅〇Dro⑽S2)細 胞表現系統可用於生產多種重組膠原蛋白,而可將之應用於科 學與醫療目的。 為使本發明之上述和其他目的、特徵、及優點能更明顯易 懂,下文特舉一較佳實施例,並配合所附圖示,作詳細說明如 下: 實施例 實施例1 : al(XXI)膠原蛋白單株抗體之生產 為生產al(XXI)膠原蛋白之C端單株抗體,合成一段對應於 人類第XXI型膠原蛋白之NCI區間936-957殘基 (CDPSLCFSVIARRDPFRKGPNY)之合成胜肽(AnaSpec,Inc)。取 2mg之純化的胜肽與鑰孔嘁血藍素(keyhole limpet hemocyanin,Pierce)結合。結合的胜肽溶液以ImmunEasy (Qiagen)乳化並經皮内注射至兩隻小鼠以標準程序生產單株抗 體(Harlow,E·,以及 Lane, D. (1988) Antibodies: a laboratory manual,Cold Spring Harbor Laboratory,Cold Spring Harbor, NY)。選擇出融合瘤3E2以進行後續實驗,並依照標準程序以蛋 白質G管柱由培養基純化總IgG。 0648-A20623TWF(N2);P13930006; chiumeow 13The present inventors demonstrated the possibility of producing activated recombinant human proline 4-hydroxylase and a collagen molecule having a stable triple helix structure in the Drosophila S2) cell expression system. In addition, these non-lytic insect cell systems also provide a convenient way to study the mechanism of collagen triple helix structure combination, especially for collagens that are under-represented in cells and tissues, which will facilitate protein-level studies. At the same time, it was found that p4H and mC21 can be stably expressed in the Drosophila S2) cell line, which means that the Drosophila 〇Dro(10)S2) cell expression system can be used to produce a variety of recombinant collagen, which can be applied to scientific and medical purposes. The above and other objects, features, and advantages of the present invention will become more apparent and understood. The production of collagen monoclonal antibody is a C-terminal monoclonal antibody producing al(XXI) collagen, and a synthetic peptide (AnaSpec) corresponding to the NCI interval 936-957 residue (CDPSLCFSVIARRDPFRKGPNY) of human XXI type collagen is synthesized. , Inc). 2 mg of the purified peptide was combined with keyhole limpet hemocyanin (Pierce). The combined peptide solution was emulsified with ImmunEasy (Qiagen) and injected intradermally into two mice to produce monoclonal antibodies by standard procedures (Harlow, E., and Lane, D. (1988) Antibodies: a laboratory manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY). Fusion tumor 3E2 was selected for subsequent experiments and total IgG was purified from the culture medium by protein G column according to standard procedures. 0648-A20623TWF(N2);P13930006; chiumeow 13

1304442 實施例2 :重組質體之構築 由人類主動脈平滑肌細胞(Clonetics)經RT-PCR增幅編碼人 類脯胺酸4-經化酶基因之α及β次單位之開放讀碼區。為了在非 胞溶之昆蟲細胞表現系統表現脯胺酸4-羥化酶,採用 InsectSelect™以及果绳誘導表現(DES⑧)系統(Invitrogen)。於 InsectSelect™系統中,分別在表現載體pIZ/V5-His之 Kpnl-Xhol、KpnI-Xbal切割位轉殖編碼人類脯胺酸4-羥化酶α及β 次單位之cDNA,並命名為ρΙΖ/Ρ4Ηα以及ρΙΖ/Ρ4Ηβ。人類脯胺酸 4-羥化酶基因之α以及β次單位的表現係在由桿狀病毒小白紋毒 蛾之多殼核多角體病毒(multicapsid nuclear polyhedrosis virus)來源的 OpIE2 啟動子所控制。 ρΙΖ/Ρ4Ηα構築體中人類脯胺酸4-經化酶基因α次單位之表現盒 係以引子ATCGATTATCATGTCTGGA(序列識別號:7)以及 CTTTGAGTGAGCATCGATC(序歹U識別號·· 8)經PCR增幅,接著 轉殖到ρΙΖ/Ρ4Ηβ的Clal切割位。所得到的構築體命名為 PIZ/P4H。於果蠅誘導表現系統中,編碼人類脯胺酸4-羥化酶α 以及β次單位之cDNA分別轉殖到表現載體pMT/V5-HisA之 NcoI_XhoI、PstI_XbaI 切割位,並命名為 ρΜΤ/Ρ4Ηα 以及 ρΜΤ/Ρ4Ηβ。人類脯胺酸4-羥化酶基因之α以及β次單位的表現係 由金屬硫肽(metallothionein)啟動子所控制,該啟動子可經由添 加銅離子或編離子而誘導。 在果蠅S2)細胞表現mC21之DNA構築體係如以 下步驟。將對應於開放讀碼區之核苷酸2484-2874的 DNA 以 引 子 5’- TTAGATCTATTCCTGGGCCACCTGGTCCGATAG-31 (序歹丨J 識別 0648-A20623TWF(N2);P13930006; chiumeow 14 I3Q4442 號·· 9)以及5f-AATCTAGACTAATAGTTTGGTCCTTTTCTG-3,(序 列識別號·· 10)經PCR增幅。將PCR產物以Bglll以及Xbal處理, 接著轉殖到表現載體PMT/BiP-V5-HisA(Invitrogen)的相同位 置。所得構築體命名為pMT/BiP-mC21。 實施例3 :建立表現P4H之穩定轉染昆蟲細胞株 在非胞溶昆蟲細胞表現系統包括擬尺蠖ηί)以 及果绳S2)細胞表現Ρ4Η的步驟如下述。1304442 Example 2: Construction of recombinant plastids The open reading frame of the alpha and beta subunits of the human proline 4-ischemase gene was amplified by RT-PCR from human aortic smooth muscle cells (Clonetics). In order to express proline 4-hydroxylase in a non-lytic insect cell expression system, InsectSelectTM and Fruit Rope Induction (DES8) system (Invitrogen) were used. In the InsectSelectTM system, the cDNA encoding the human proline 4-hydroxylase α and β subunits was transduced in the Kpnl-Xhol and KpnI-Xbal cleavage sites of the expression vector pIZ/V5-His, respectively, and designated as ρΙΖ/ Ρ4Ηα and ρΙΖ/Ρ4Ηβ. The alpha and beta subunits of the human proline 4-hydroxylase gene are under the control of the OpIE2 promoter from the multicapsid nuclear polyhedrosis virus of the baculovirus. The expression cassette of the human valerine 4-transferase gene α-subunit in the ρΙΖ/Ρ4Ηα construct was amplified by PCR with the primers ATCGATTATCATGTCTGGA (SEQ ID NO: 7) and CTTTGAGTGAGCATCGATC (Sequence 歹 U number 8). Transfer to the Clal cleavage site of ρΙΖ/Ρ4Ηβ. The resulting construct was named PIZ/P4H. In the Drosophila-inducible expression system, cDNA encoding human proline 4-hydroxylase α and β-subunits were transfected into the NcoI_XhoI and PstI_XbaI cleavage sites of the expression vector pMT/V5-HisA, and designated as ρΜΤ/Ρ4Ηα and ρΜΤ/Ρ4Ηβ. The expression of the alpha and beta subunits of the human proline 4-hydroxylase gene is controlled by the metallothionein promoter, which can be induced by the addition of copper ions or ions. The DNA construct system of mC21 is expressed in Drosophila S2) cells as follows. The DNA corresponding to nucleotides 2484-2874 of the open reading region is referred to as 5'- TTAGATCTATTCCTGGGCCACCTGGTCCGATAG-31 (the sequence 0J identifies 0648-A20623TWF(N2); P13930006; chiumeow 14 I3Q4442··9) and 5f- AATCTAGACTAATAGTTTGGTCCTTTTCTG-3, (sequence identification number··10) was amplified by PCR. The PCR product was treated with Bglll and Xbal, and then transferred to the same position as the expression vector PMT/BiP-V5-HisA (Invitrogen). The resulting construct was named pMT/BiP-mC21. Example 3: Establishment of a stable transfected insect cell line expressing P4H The steps of expressing the cell in the non-lytic insect cell expression system and the fruit line S2) are as follows.

(1)擬尺蝮wz·)細胞 於 InsectSelect™ 系統中,以 Superfect transfection 試劑 (Qiagan)將 pIZ/P4H 轉染至擬尺蠖πζ·)細胞(High Five,Invitrogen)。轉染後,以最終濃度400 pg/ml之抗生素zeocine 選擇4週取得細胞。由對抗生素具有抗性之轉殖株取十株分離狀 態較佳之轉殖株,並以抗Ρ4Ηα以及Ρ4Ηβ之單株抗體(購自ICN, Ins.)進行西方墨點分析,以分析每個穩定轉殖株細胞溶胞產物 中P4Hcx以及Ρ4Ηβ之蛋白質表現。西方墨點分析步驟係如下說 明。採用10% NuPAGE bis-Tris聚丙烯醯胺膠體與嗎林乙石黃酸 (morpholineethanesulfonic acid,簡稱MES)緩衝液(Invitrogen)進 行 SDS-PAGE,並以 Simple Blue Safestain試劑(Invitrogen)染色。 經SDS-PAGE後,將蛋白質轉印到硝基纖維素膜。以含〇.ι〇/0 Tween-20之PBS的5%脱脂牛奶封阻蛋白質,並以抗體探測。結 合抗體係以過氧化酶結合二次抗體彳貞測,並以SuperSignal彳貞測 試劑(Pierce)呈色。採用光密度計定量X-光片。選擇顯示ρ4Ηα 高表現量的轉殖株進行後續實驗。 比較擬尺蠖細胞溶胞產物中之Ρ4Ηα以及Ρ4Ηβ表現程度,如 第1Α圖所示,P4Hcx之蛋白質表現程度僅約為Ρ4Ηβ的五分之一。 0648-A20623TWF(N2);P13930006; chiumeow(1) 拟 蝮wz·) cells In the InsectSelectTM system, pIZ/P4H was transfected into the 蠖π蠖·) cells (High Five, Invitrogen) with Superfect transfection reagent (Qiagan). After transfection, cells were harvested for 4 weeks with antibiotic zeocine at a final concentration of 400 pg/ml. Ten transgenic plants with good resistance to antibiotics were obtained, and Western blot analysis was performed with monoclonal antibodies against Ρ4Ηα and Ρ4Ηβ (purchased from ICN, Ins.) to analyze each stability. The protein expression of P4Hcx and Ρ4Ηβ in the cell lysate of the transgenic strain. Western blot analysis steps are described below. SDS-PAGE was performed using 10% NuPAGE bis-Tris polypropylene guanamine colloid and morpholineethanesulfonic acid (MES) buffer (Invitrogen) and stained with Simple Blue Safestain reagent (Invitrogen). After SDS-PAGE, the protein was transferred to a nitrocellulose membrane. The protein was blocked with 5% skim milk containing 〇.ι〇/0 Tween-20 in PBS and probed with antibodies. The binding anti-system was assayed by peroxidase-conjugated secondary antibody and stained with SuperSignal assay reagent (Pierce). The X-ray film was quantified using a densitometer. Subsequent experiments were performed to select transgenic plants showing high expression of ρ4Ηα. The degree of expression of Ρ4Ηα and Ρ4Ηβ in the cell lysate of the sputum sputum was compared. As shown in Fig. 1, the protein expression of P4Hcx was only about one fifth of that of Ρ4Ηβ. 0648-A20623TWF(N2); P13930006; chiumeow

1304442 (2)果蠅S2細胞 為於果蠅誘導表現系統表現P4H,採用Effectene轉染試劑 (Qiagen)將ρΜΤ/Ρ4Ηα,ρΜΤ/Ρ4Ηβ,以及pCoHygro(三者比例為 10:10:1)共同轉染果蠅S2)細胞。轉染後,以最終濃 度300 pg/ml之效高黴素(hygromycin Β)選擇4週取得細胞。Ρ4Ηα 以及Ρ4Ηβ之表現係由金屬硫肽(metallothionein)啟動子所控 制,經由添加銅離子而誘導。在添加0.5 mM之硫酸銅至培養細 胞後,使細胞生長120小時,如第1B圖所示,與未誘導之對照組 (第1B圖,第1、3欄)比較,誘導後(第1B圖,第2、4攔)Ρ4Ηα以 及Ρ4Ηβ之蛋白質表現程度皆大幅增加。 為檢測是否上述非胞溶昆蟲系統所生產之重組Ρ4Η具有功 能活性,採用基於2-氧[1_14C]戊二酸之去羧化(Kivirikko, Κ· I·, 以及 Myllyla,R. (1982) Methods Enzymol. 82,245-304)的方法 測試擬尺蠖與果蠅細胞中表現的P4H酵素活性。結果如表I所 示0 表I:擬尺蠖與果蠅S2細胞中重組脯胺酸4-羥化酶活性之試驗 細胞溶胞產物 脯胺酸4-羥化酶活性a l00μgb Dpm 擬尺墣/π·)細胞 未轉染對照組 55 土 15 轉染P4H者 101土24 果蠅S2)細胞 未轉染對照組 172+22 轉染P4H,未誘導者 271 土 23 轉染P4H,經Cu2+誘導者 356土 37 0648-A20623TWF(N2);P13930006; chiumeow 16 13,04442 本试驗係基於2 -乳[1 - C ]戊一酸之私化結合去魏化採用 合成胜肽(GPP)1()作為受質。 b細胞係於含有0.2%Triton X-100之緩衝液打破,且每試 驗採用約100 pg之溶解的細胞萃取物。轉染P4H之果绳細胞係 在誘導120小時後收取。1304442 (2) Drosophila S2 cells express P4H in the Drosophila-induced expression system, and use the Effectene transfection reagent (Qiagen) to transfer ρΜΤ/Ρ4Ηα, ρΜΤ/Ρ4Ηβ, and pCoHygro (the ratio of the three is 10:10:1) Dyed Drosophila S2) cells. After transfection, cells were harvested for 4 weeks at a final concentration of 300 pg/ml of hygromycin. The expression of Ρ4Ηα and Ρ4Ηβ is controlled by the metallothionein promoter and induced by the addition of copper ions. After adding 0.5 mM copper sulfate to the cultured cells, the cells were allowed to grow for 120 hours, as shown in Fig. 1B, compared with the uninduced control group (Fig. 1B, columns 1, 3), after induction (Fig. 1B). , 2nd and 4th blocks) The protein expression levels of Ρ4Ηα and Ρ4Ηβ were greatly increased. To detect whether the recombinant Ρ4Η produced by the above non-lytic insect system is functionally active, decarboxylation based on 2-oxo[1_14C]glutaric acid is employed (Kivirikko, Κ·I·, and Myllyla, R. (1982) Methods The method of Enzymol. 82, 245-304) tested the activity of P4H enzymes in the cells of Drosophila and Drosophila. The results are shown in Table I. Table I: Test of recombinant proline 4-hydroxylase activity in Drosophila and Drosophila S2 cells Cell lysate proline 4-hydroxylase activity a l00μgb Dpm π·) cells were not transfected into control group 55 soil 15 transfected with P4H 101 soil 24 Drosophila S2) cells were not transfected into control group 172+22 transfected with P4H, uninduced 271 soil 23 transfected with P4H, induced by Cu2+ 356土37 0648-A20623TWF(N2); P13930006; chiumeow 16 13,04442 This test is based on the chemotactic combination of 2 -milk [1 - C] pentanoic acid and de-transformation using synthetic peptide (GPP) 1 () As a quality. The b cell line was disrupted in buffer containing 0.2% Triton X-100 and approximately 100 pg of dissolved cell extract was used per assay. The fruit line cell line transfected with P4H was collected 120 hours after induction.

如表I所示,擬尺墁(7>/cA(^/⑽Μ /π·)細胞單獨含有微量内 源性脯胺酸4-經化酶活性,如之前報告所揭露(Lamberg,Α·,等 人(1996) J Biol Chem 271,11988-11995)。在穩定轉染細胞株中 之P4H活性會增加不到未轉染對照組中内源性酵素的2倍。有 趣的是’同樣含Η的溶解細胞蛋白質’果塊S2)細胞 中内源性脯胺酸4-羥化酶活性是穩定轉染P4H之擬尺墣細胞株 的1.7倍。未轉染與Cu2+誘導之穩定轉染P4H的果蠅S2細胞株 中,P4H活性會比未轉染之對照組分別增加約1.6以及2倍。上 述結果顯示’於未胞溶形式下表現重組P4H,果绳S2) 系統較擬尺墁系統為佳。因此,選擇果繩 S2)系統進行後續小型第XXI型膠原蛋白之表現。 實施例4 : mC21之重組表現 本發明人原希望在帶有上述穩定轉染P4H基因之擬尺蠖與 果蠅細胞系統表現全長αΐ (XXI)膠原蛋白,然而,採用抗αΐ (XXI) 膠原蛋白抗體以西方墨點分析兩系統中重組膠原蛋白產物顯 示,全長al(XXI)膠原蛋白分子會降解成數個不同的小片段(數 據未顯示)。之前對於雞小型第XII型膠原蛋白之三元體組合研 究發現,三螺旋結構形成是起始於C端膠原蛋白三螺旋區間 (Mazzorana,Μ·,等人(2001) J Biol Chem 276,27989-27998) 〇 為了解al(XXI)膠原蛋白分子之C端膠原蛋白三螺旋區間是否 0648-A20623TWF(N2);P13930006; chiumeow 17 1304442 可啟動三元體組合成功能性三螺旋結構,將包括完整c端無膠 原蛋白(NC1)以及膠原蛋白三螺旋區間(COL1)之mC21表現於果 繩S2)細胞。As shown in Table I, the cells of the genus 7(7>/cA(^/(10)Μ /π·) contain a small amount of endogenous glutamate 4-transferase activity, as disclosed in the previous report (Lamberg, Α·, Et al. (1996) J Biol Chem 271, 11988-11995). P4H activity in stably transfected cell lines increased less than 2 times that of endogenous enzymes in untransfected controls. Interestingly, 'the same Η The endogenous proline 4-hydroxylase activity in the lysed cell protein 'fruit S2) cells was 1.7 times higher than that of the P4H-infected cell line. In the Drosophila S2 cell line that was not transfected with Cu2+-induced stable transfection of P4H, the P4H activity increased by about 1.6 and 2 times, respectively, compared to the untransfected control group. The above results show that the system exhibiting recombinant P4H in the un-cytosolic form, the fruit rope S2) system is better than the ruler system. Therefore, the fruit rope S2) system was selected for subsequent small XXI type collagen expression. Example 4: Recombinant Expression of mC21 The present inventors originally intended to express full-length αΐ (XXI) collagen in the Drosophila and Drosophila cell systems carrying the above-described stably transfected P4H gene, however, anti-αΐ (XXI) collagen antibody was used. Analysis of recombinant collagen products in both systems by Western blot analysis revealed that the full-length al(XXI) collagen molecules degraded into several distinct small fragments (data not shown). Previous studies on the ternary combination of chicken small type XII collagen revealed that the formation of the triple helix was initiated by the C-collagen triple helix region (Mazzorana, Μ·, et al. (2001) J Biol Chem 276, 27989- 27998) 了解 To understand whether the C-terminal collagen triple helix of the al(XXI) collagen molecule is 0648-A20623TWF(N2); P13930006; chiumeow 17 1304442 The startable ternary body is combined into a functional triple helix structure, which will include the complete c The mC21 with no collagen (NC1) and collagen triple helix (COL1) is expressed in the fruit rope S2) cells.

第2Α圖顯示推定的重組mC21 —級序列。果蠅表現構築體 pMT/BiP-mC21含有在mC21之N端編碼果蠅BiP訊號序列(陰 影區)以供分泌時使用,NC2區間之最後4個胺基酸殘基,人類 ocl(XXI)膠原蛋白之完整COL1區間以及NC1區間,以及一 C 端組胺酸標籤等序列。訊號胜肽切除後所推定的N端係以下方 箭頭指出。XYG三序列之Y位置的脯胺酸殘基推測已經羥化 (Kivirikko, Κ· I·,等人 (1992) In Post-Translational Modifications of Proteins (Harding,J. J·,and Crabbe,M. J. C·, Eds_) CRC Press, Boca Raton,FL·,1-51)以黑點標示。FACIT 膠 原蛋白家族中,特徵性的兩個GXY瑕疵以及在COL1/NC1接界 與鏈間雙硫交橋相關之兩半胱胺酸殘基分別以斜體字以及黑體 字表示。 為表現mC21,將pMT/BiP-mC21與pCoBlast載體共同轉 染至果繩S2)細胞、或已含有功能性P4H之穩定轉 鲁 殖株。於果繩S2)系統中,由於S2細胞並不會在低 於2 X 1〇5細胞/ml之細胞密度下存活,並不容易由一轉殖之盤 中選擇出單獨株。因此以最終濃度30 pg/ml之抗生素biastcidine 選擇三週後,同一盤取得之全部轉殖株皆匯合為一穩定細胞 株。將細胞溶胞產物以及培養基皆採用單株抗體3E2進行西方 墨點分析,上述單株抗體3E2可辨認al(XXI)膠原蛋白之c端 NC1區間。結果如第2Β圖所不。將由穩疋轉染之果绳細胞經 Cu2+誘導後120小時取得之培養基進行電泳,採用1〇%之 SDS/Bis-Tris聚丙烯醯胺膠體及MES緩衝液,在未還原(第1以 0648-A20623TWF(N2);P13930006; chiumeow 18Figure 2 shows the putative recombination mC21-level sequence. The Drosophila Expression Construct pMT/BiP-mC21 contains the Drosophila BiP signal sequence (shaded area) at the N-terminus of mC21 for secretion, the last 4 amino acid residues in the NC2 region, human ocl (XXI) collagen The complete COL1 and NC1 regions of the protein, as well as a C-terminal histidine tag. The N-terminal line estimated after the signal peptide is removed is indicated by the arrow below. The proline residue at the Y position of the XYG triple sequence is presumed to have been hydroxylated (Kivirikko, Κ·I·, et al. (1992) In Post-Translational Modifications of Proteins (Harding, J. J., and Crabbe, MJ C· , Eds_) CRC Press, Boca Raton, FL·, 1-51) are indicated by black dots. In the FACIT collagen family, the two characteristic GXY瑕疵 and the two cysteine residues associated with the COL1/NC1 junction and the interchain disulfide bridge are indicated in italics and in boldface, respectively. To express mC21, pMT/BiP-mC21 and pCoBlast vector were co-transfected into fruitline S2) cells or stable transgenic plants containing functional P4H. In the fruit rope S2) system, since S2 cells do not survive at a cell density lower than 2 X 1〇5 cells/ml, it is not easy to select a single strain from a plate. Therefore, after three weeks of selection of the antibiotic biastcidine at a final concentration of 30 pg/ml, all of the transgenic plants obtained in the same dish were confluent into a stable cell strain. The cell lysate and the medium were subjected to Western blot analysis using monoclonal antibody 3E2, and the monoclonal antibody 3E2 described above recognized the c-terminal NC1 region of al(XXI) collagen. The result is as shown in Figure 2. The medium obtained from the stably transfected fruit rope cells was electrophoresed 120 hours after Cu2+ induction, and 1%% of SDS/Bis-Tris polypropylene guanamine colloid and MES buffer were used, which was not reduced (1st to 0648- A20623TWF(N2);P13930006; chiumeow 18

1304442 及2櫊)以及還原(第3行)狀態下,再以辨認αΐ (XXI)膠原蛋白之 C端的單株抗體3Ε2進行免疫墨點法分析。 結果發現mC21獨獨表現於培養基,即成為溶解形式,代 表果蠅BiP訊號序列成功導引該蛋白質之分泌。當mC21穩定 地表現於果蠅時,可偵測到兩個主要電泳帶對應於mC21單體 以及鏈間雙硫鍵二元體,分別為20以及40 kD之分子量大小, 如第2B圖第1欄所示。然而,在有P4H穩定轉染的果蠅細胞 株,mC21可組合成鏈間雙硫鍵同質三元體(60 kD),如第2欄 所示。將有P4H穩定轉染的果蠅細胞株所生產之mC21還原, 顯示出所得到的二元體以及三元體皆可被還原(第3欄)。這些結 果代表,在果蠅細胞表現系統中,需要有足夠量 的活化重組脯胺酸4-羥化酶進行雙硫鍵三元體mC21分子之組 合0 實施例5 :於穩定轉染果蠅S2細胞中持續表現三人類基因 為測試是否共同轉染含有三基因:Ρ4Η(χ,Ρ4Ηβ,以及mC21 果蠅轉殖株可持續生產重組蛋白質,本發明人進行一 6天時程 實驗,採用各蛋白質對應的抗體以西方墨點分析每個蛋白質。 實驗開始時,將表現穩定轉染之mC21以及/或P4H基因的果 蠅S2細胞培養於含有無血清培養基(Hyclone)之震盪培養瓶。細 胞以4 X 106細胞/ml之密度分種於培養瓶,並維持1 X 107細胞 /ml。添加0.5 mM之硫酸銅至培養基以誘導重組蛋白質之表現, 並生長經歷不同時間。每天添加抗壞血酸鈉(80 pg/ml)至培養基 以供給含有mC21 cDNA構築體之轉殖株。西方墨點分析結果如 第3圖所示。第1欄顯示未誘導對照組。結果顯示經過5天所取得 之細胞溶胞產物具有增加量的Ρ4Ηα以及Ρ4Ηβ。在果蠅穩定轉染 0648-A20623TWF(N2);P13930006; chiumeow 19In the state of 1304442 and 2櫊) and the reduction (line 3), the monoclonal antibody 3Ε2 of the C-terminal of αΐ (XXI) collagen was identified for immunoblotting analysis. It was found that mC21 was expressed in the medium alone, i.e., in a dissolved form, and the Drosophila BiP signal sequence successfully guided the secretion of the protein. When mC21 is stably expressed in Drosophila, two main electrophoresis bands can be detected corresponding to mC21 monomer and interchain disulfide bond, which are molecular weights of 20 and 40 kD, respectively, as shown in Figure 2B. As shown in the column. However, in Drosophila cell lines stably transfected with P4H, mC21 can be combined into an interchain disulfide homogenous ternary (60 kD), as shown in column 2. Reduction of mC21 produced by a D4 fly-transfected Drosophila cell line showed that both the obtained binary and ternary bodies were reduced (column 3). These results represent that in the Drosophila cell expression system, a sufficient amount of activated recombinant proline 4-hydroxylase is required for the combination of the disulfide triplet mC21 molecules. Example 5: Stable transfection of Drosophila S2 The three human genes are continuously expressed in the cells to test whether the three genes are commonly transfected: Ρ4Η(χ,Ρ4Ηβ, and mC21 Drosophila transgenic plants can continuously produce recombinant proteins, and the inventors performed a 6-day time-lapse experiment using each protein. Corresponding antibodies were analyzed for each protein with Western blots. At the beginning of the experiment, Drosophila S2 cells expressing stably transfected mC21 and/or P4H genes were cultured in shake flasks containing serum-free medium (Hyclone). The density of X 106 cells/ml was seeded in a culture flask and maintained at 1 X 107 cells/ml. 0.5 mM copper sulfate was added to the medium to induce the expression of the recombinant protein, and growth was carried out for different times. Sodium ascorbate was added daily (80 pg /ml) to the medium to supply the transgenic strain containing the mC21 cDNA construct. Western blot analysis results are shown in Fig. 3. Column 1 shows that the control group was not induced. The cell lysate obtained by the day has an increased amount of Ρ4Ηα and Ρ4Ηβ. Stable transfection in Drosophila 0648-A20623TWF(N2); P13930006; chiumeow 19

13044421304442

株所生產的Ρ4Ηβ在誘導後第2天達到最大量,而ρ4Ηα需5天時間 方達到最大量表現。mC21之三種型態的表現強度在誘導後第5 天達到最大。mC21之鏈間雙硫鍵三元體(T)形式在誘導後第私 小時開始測到,之後持續增加直到誘導後第5天才達到最大量。 特別是Ρ4Ηα以及mC2l三元體之表現程度隨著時間進程而增 加,代表果蠅細胞中需顯著量催化性ρ4Ηα以輔助形成第父义1型 膠原蛋白之鏈間雙硫鍵三元體。在誘導後約1個月,再度比較不 同繼代之穩定轉染株中Ρ4Ηα,Ρ4Ηβ,以及mC21的含量。發現 三基因之表現強度在同一繼代中約為相同,代表果蠅穩定轉殖 株可穩定地生產三重組蛋白質(數據未顯示)。 實施例6 :經純化之重組小型膠原蛋白XXI的特性分析 不論是否與P4H共同表現,將果繩S2細胞中之重組 由培養基經以下管柱層析步驟純化。 以0·5 mM之硫酸銅誘導穩定轉染果蠅S2細胞表現mC21以 及P4H,並將細胞於27 °C下培養於條件培養基120小時。取約300 ml之過濾的培養基,其中含有C端His-楳籤小型膠原蛋白,投入 事先以20 mM乙酸鈉緩衝液,pH 6.0,以60 ml/h之流速平衡過之 無負載的His-Bind Fractogel管柱(1·5 X 8 cm,Novagen)。在以同 樣的緩衝液清洗後,以含有0·1 Μ咪唑之同樣緩衝液將小型膠原 蛋白沖提出來。監控280nm波長之UV吸光度,收集出現波峰、 含有小型膠原蛋白之級分,將之匯合在一起’並以20 mM之乙 酸鈉緩衝液,pH 6.0,於4°C隔夜透析。透析產物投入事先以20 mM乙酸鈉缓衝液,pH 6.0,以60 ml/h之流速平衡過之HlghTrap sulfopropyl管柱(1-ml空床體積)。管柱先以50mM2NaC1清洗, 再將結合的小型膠原蛋白以含有〇·25 M NaCl之上述缓衝液沖提 0648-A20623TWF(N2);P13930006; chiumeow 20 1304442 t t 出來。收集波峰級分並投入事先經含有0·1 M NaCl之50 mM乙 酸鈉緩衝液,pH 6.0,以60 ml/h之流速平衡過、經ZnS04處理之 螯合瓊脂糖HighTrap管柱(Ι-ml空床體積)。管柱先以25 mM之咪 唑清洗,再將結合的小型膠原蛋白以含有0·25 Μ咪唑之上述緩 衝液沖提。最後將產物以50 mM之乙酸鈉,pH 6.0透析。不論是 否與P4H共同表現,在硫酸銅誘導5天後,果蠅S2細胞中mC21 的表現程度約為〜3 mg/1,與所獲得純化並回收的mC21所估計量 相當(數據未顯示)。蛋白質濃度係以標準程序採用牛血清白蛋 白,以羅瑞士試驗(Lowry assay)測定。 純化的重組mC21樣品經電泳分析,採用1 〇% SDS/Bis-Tris 聚丙烯醯胺與MES緩衝液,如第4圖所示,還原狀態為第1以 及3欄,非還原狀態為第2以及4欄。膠體係以Simple Blue Safestain試劑染色。三個主要染色帶對應於mC21之鏈間雙硫鍵 三元體(T)、二元體(D)、以及無雙硫鍵單體分子(M)(第4圖之第 2及4欄),在SDS-PAGE中未還原狀態下移行為成對染色帶, 如之前西方墨點分析所觀察結果(第2B圖)。將每個三元體、二 元體、及單體分子之成對染色帶的各別蛋白質由SDS-聚丙烯醯 胺膠體上切下,採用定序級胰蛋白酶(Promega)依已建立的程序 處理。回復的胜肽以 MALDI_TOF(Matrix-Assisted Laser Desorption Ionization Time-of-Flight)分析儀(ABI 4700 Proteomics analyzer)分析胜肽圖譜。結果確認每個成對蛋白質之 間並無mC21胜肽片段分子量差異,代表這些成對蛋白質係由 某些殘留的二級結構造成,即使使用了 SDS,或非鏈間雙硫鍵 的種類(數據未顯示)也沒能消除。這些mC21可在還原狀態下還 原成成對的單體(第4圖第1以及3欄)。 為直接證明重組mC21中存在有羥化脯胺酸,如穩定轉染 0648-A20623TWF(N2);P13930006; chiumeow 21 1304442The Ρ4Ηβ produced by the strain reached its maximum amount on the second day after induction, while ρ4Ηα took 5 days to reach the maximum amount. The intensity of the three types of mC21 reached its maximum on the 5th day after induction. The interchain disulfide triplet (T) form of mC21 was measured at the first hour after induction and continued to increase until the maximum amount was reached on the 5th day after induction. In particular, the degree of expression of Ρ4Ηα and mC2l ternary bodies increased with time, indicating that a significant amount of catalytic ρ4Ηα was required in Drosophila cells to assist in the formation of interchain disulfide triplets of the first paternal type 1 collagen. About 1 month after induction, the contents of Ρ4Ηα, Ρ4Ηβ, and mC21 in stable transfectants of different passages were again compared. It was found that the intensity of the three genes was about the same in the same passage, indicating that the stable transgenic strain of Drosophila stably produced three recombinant proteins (data not shown). Example 6: Characterization of purified recombinant small collagen XXI Recombination in fruit rope S2 cells was purified from the medium by the following column chromatography step, whether or not it was performed together with P4H. The stably transfected Drosophila S2 cells were expressed as mC21 and P4H with 0.5 mM copper sulfate, and the cells were cultured in conditioned medium at 27 °C for 120 hours. Approximately 300 ml of the filtered medium containing the C-terminal His-楳-small collagen was loaded into a pre-loaded His-Bind with 20 mM sodium acetate buffer, pH 6.0, at a flow rate of 60 ml/h. Fractogel column (1·5 X 8 cm, Novagen). After washing with the same buffer, the small collagen was flushed out in the same buffer containing 0.1 M imidazole. The UV absorbance at a wavelength of 280 nm was monitored, peaks containing fractions of small collagen were collected, pooled together and dialyzed overnight at 4 ° C with 20 mM sodium acetate buffer, pH 6.0. The dialysis product was loaded with a HlghTrap sulfopropyl column (1-ml empty bed volume) previously equilibrated with 20 mM sodium acetate buffer, pH 6.0, at a flow rate of 60 ml/h. The column was first washed with 50 mM 2 NaCl, and the bound small collagen was eluted with the above buffer containing 〇·25 M NaCl. 0648-A20623TWF(N2); P13930006; chiumeow 20 1304442 t t came out. The peak fraction was collected and a chelating agarose HighTrap column (Ι-ml) previously equilibrated with ZnS04 at a flow rate of 60 ml/h in 50 mM sodium acetate buffer, pH 6.0 containing 0.1 M NaCl. Empty bed volume). The column was first washed with 25 mM of imidazole, and the bound small collagen was eluted with the above buffer containing 0·25 imidazole. Finally the product was dialyzed against 50 mM sodium acetate, pH 6.0. Whether or not co-expressed with P4H, mC21 expression in Drosophila S2 cells was approximately ~3 mg/1 after 5 days of copper sulfate induction, comparable to the estimated amount of purified and recovered mC21 obtained (data not shown). The protein concentration was determined using a bovine serum albumin using a standard procedure using the Lowry assay. The purified recombinant mC21 sample was analyzed by electrophoresis using 1% SDS/Bis-Tris polypropylene guanamine and MES buffer. As shown in Fig. 4, the reduction state was column 1 and column 3, and the non-reduction state was 2nd. 4 columns. The gum system was stained with Simple Blue Safestain reagent. The three main dye bands correspond to the interchain disulfide triplet (T), the binary (D), and the disulfide free monomer molecule (M) of mC21 (columns 2 and 4 of Figure 4). In the unreduced state in SDS-PAGE, the paired dyeing bands were observed, as observed by Western blot analysis (Fig. 2B). The individual proteins of the paired dye bands of each of the ternary, binary, and monomeric molecules were cleaved from the SDS-polyacrylamide colloid, using a sequence of trypsin (Promega) according to established procedures. deal with. The recovered peptide was analyzed by a MALDI_TOF (Matrix-Assisted Laser Desorption Ionization Time-of-Flight) analyzer (ABI 4700 Proteomics analyzer). The results confirmed that there was no molecular weight difference between the mC21 peptide fragments between each pair of proteins, indicating that these paired proteins were caused by some residual secondary structure, even if SDS, or the type of non-chain disulfide bond was used (data Not shown) has not been eliminated. These mC21 can be reduced to a pair of monomers in the reduced state (columns 1 and 3 of Figure 4). To directly demonstrate the presence of hydroxylated proline in recombinant mC21, such as stable transfection 0648-A20623TWF (N2); P13930006; chiumeow 21 1304442

果蠅S2細胞中之脯胺酸4-羥化酶所處理者,將純化樣品進行胺 基酸組成與質譜分析。胺基酸分析時,將純化的重組mC21以 50 mM乙酸透析,於110 0C以6 N之HC1水解24小時,再以 Beckman系統6300胺基酸分析儀進行胺基酸分析。結果如表II 所示。 表II:果蠅S2細胞中單獨或與人類脯胺酸4-羥化酶共同轉染之 純化的重組人類小型膠原蛋白XXI之胺基酸分析The purified sample was subjected to amino acid composition and mass spectrometry after treatment with proline 4-hydroxylase in Drosophila S2 cells. For amino acid analysis, purified recombinant mC21 was dialyzed against 50 mM acetic acid, hydrolyzed with 6 N of HCl at 110 °C for 24 hours, and subjected to amino acid analysis using a Beckman System 6300 Amino Acid Analyzer. The results are shown in Table II. Table II: Analysis of Amino Acids of Purified Recombinant Human Small Collagen XXI in Drosophila S2 Cells Transfected Individually or with Human Proline 4-Hydroxygenase

胺基酸 重組人類小型膠原蛋白XXI 計算結果a 未轉染P4H 共同轉染P4Hb (從 cDNA) 殘基e Asx 9.4+1.9 10.6+0.2 10 Glx 14.4+4.3 11·6±0·4 9 Hyp 2.4+0.1 5.5 土 0·2 - Ser 8.5土1_8 9_9 土 0·2 10 Gly 29_8 土 2.9 27.1+0.5 37 His 10.0+1.2 9.5+0.5 7 Arg 8.5+0.5 8.9+0.2 9 Thr 1.6+0.4 2.0+0.2 0 Ala 3.0+0.5 3.5+0.3 1 Pro 23.2 土 1.3 20.3 土 2.2 31 Tyr 2.9+0.3 3·0 土 0.3 2 Val 5.6 土 0.3 5.3+0.1 5 Met 0.5+0.3 0.4+0.1 0 Cys 1.4+0.2 1.6+0.6 2 0648-A20623TWF(N2);P13930006; chiumeow 22Amino acid recombinant human small collagen XXI calculation result a untransfected P4H co-transfected P4Hb (from cDNA) residue e Asx 9.4+1.9 10.6+0.2 10 Glx 14.4+4.3 11·6±0·4 9 Hyp 2.4+ 0.1 5.5 soil 0·2 - Ser 8.5 soil 1_8 9_9 soil 0·2 10 Gly 29_8 soil 2.9 27.1+0.5 37 His 10.0+1.2 9.5+0.5 7 Arg 8.5+0.5 8.9+0.2 9 Thr 1.6+0.4 2.0+0.2 0 Ala 3.0+0.5 3.5+0.3 1 Pro 23.2 Soil 1.3 20.3 Earth 2.2 31 Tyr 2.9+0.3 3·0 Soil 0.3 2 Val 5.6 Soil 0.3 5.3+0.1 5 Met 0.5+0.3 0.4+0.1 0 Cys 1.4+0.2 1.6+0.6 2 0648 -A20623TWF(N2);P13930006; chiumeow 22

1304442 lie 5.0+0.6 5.3 土 0·1 6 Leu 7_8 土 1·9 8·9 土 0.2 8 Phe 4.7+0.6 4.1+0.2 3 Lys 7.4+1.2 8.3+0.1 6 Hyp/Pro = 0.10 0.27 % 9 21 Hyp/(Hyp+P ro )= a計算胺基酸殘基係基於推測移除果蠅BiP訊號序列後之 mC21胺基酸序列,如第2A圖所示。 b純化之mC21係由銅誘導後120小時之細胞。 e所列數値為平均值土標準差,η = 2。 如表II所示,由果蠅S2細胞純化之mC21的胺基酸組成, 不論是否與P4H共同轉染,皆與基於cDNA胺基酸序列所推測 組成具有一致性。mC21中羥化程度(羥化脯胺酸殘基對於總脯 胺酸殘基加羥化脯胺酸殘基之比例),單獨或與P4H共同轉染者 分別為9以及21%。脯胺酸殘基完全羥化的理論値為17(第2A 圖),且羥化度為54.8%。所得結果顯示穩定轉染P4H之果蠅S2 細胞中所共同表現之mC21分子的脯胺酸殘基並未完全羥化, 不過自然界第XXI型膠原蛋白之羥化量也屬未知。為進一步檢 驗mC21多胜肽鏈脯胺酸羥化程度,將純化過的mC21以胰蛋白 酶消化處理,再以MALDI-TOF質譜儀分析。選擇由果蠅S2細 胞單獨表現(第5A圖)或與P4H共同表現(第5B圖)之mC21取 得之兩胰蛋白酶消化胜肽片段進行比對。不論是否與PH4同時 表現於果蠅S2細胞中,將重組mC21以10% SDS/Bis-Tris聚丙 0648-A20623TWF(N2);P13930006; chiumeow 231304442 lie 5.0+0.6 5.3 Soil 0·1 6 Leu 7_8 Soil 1·9 8·9 Soil 0.2 8 Phe 4.7+0.6 4.1+0.2 3 Lys 7.4+1.2 8.3+0.1 6 Hyp/Pro = 0.10 0.27 % 9 21 Hyp/ (Hyp+P ro )= a Calculate the amino acid residue based on the mC21 amino acid sequence after presumably removing the Drosophila BiP signal sequence, as shown in Figure 2A. b Purified mC21 is a cell 120 hours after induction by copper. The number listed in e is the mean soil standard deviation, η = 2. As shown in Table II, the amino acid composition of mC21 purified from Drosophila S2 cells, whether or not co-transfected with P4H, was consistent with the putative composition based on the cDNA amino acid sequence. The degree of hydroxylation in mC21 (the ratio of hydroxylated proline residues to total proline residues plus hydroxylated valerine residues) was 9 and 21%, respectively, either alone or in combination with P4H. The theoretical enthalpy of complete hydroxylation of the proline residue is 17 (Fig. 2A) and the degree of hydroxylation is 54.8%. The results showed that the proline residues of the mC21 molecule co-expressed in the D2 cells stably transfected with P4H were not completely hydroxylated, but the hydroxylation amount of the XXI collagen in nature was also unknown. To further examine the degree of hydroxylation of the mC21 polypeptide chain proline, the purified mC21 was digested with trypsin and analyzed by MALDI-TOF mass spectrometry. The trypsin digested peptide fragments obtained by mC21 of Drosophila S2 cells alone (Fig. 5A) or with P4H (Fig. 5B) were selected for alignment. Recombinant mC21 with 10% SDS/Bis-Tris polypropyl 0648-A20623TWF(N2); P13930006; chiumeow 23 whether or not it is expressed in Drosophila S2 cells simultaneously with PH4

1304442 ^ >1304442 ^ >

烯醯胺膠體與MES緩衝液,於還原狀態下進行電泳分析。蛋白 質染色帶係以Simple Blue Safestain試劑染色,以胰蛋白酶進行 膠體上酵素處理,並經MALDI-TOF質譜分析。分別選擇為果 蠅S2細胞單獨表現mC21(mC21AP4H,第5A圖)以及與穩定轉 染之P4H共同表現之mC21(mC21/P4H,第5B圖)的胰蛋白酶處 理片段。推測XYG三序列上Y位置的脯胺酸殘基有羥化者以黑 點標示。結果顯示,果蠅S2細胞中單獨或與P4H共同表現之胜 肽片段仍具有實質上未羥化分子片段,分別為分子量1531.86 以及1583.86。基於每個胜肽增加之氧原子分子量,發現胰蛋白 酶消化片段也有單-及二-羥化胜肽。在穩定轉染P4H之S2細胞 中,羥化對於未羥化胜肽分子之相對強度實質上高於未轉染 P4H細胞(參見第5圖,比較A與B),此結果與小型膠原蛋白分 子之總胺基酸組成分析結果一致。 ,實施例7 ··小型膠原蛋白XXI之三螺旋結構 膠原蛋白三螺旋結構對於胃蛋白酶降解具有抗性。為確認 是否mC21之COL1區間為三螺旋結構,將單獨或與P4H共同 表現之純化過的mC21,以0.5 Μ之乙酸培養於22 °C以及37 °C 15分鐘以達到pH 2.5,之後以胃蛋白酶(25 pg/ml)消化處理2 小時,而測試其螺旋結構穩定性。若mC21為三螺旋結構,則 胃蛋白酶應僅能除去NC1區間,得到COL1/NC1接界有兩個半 胱胺酸之COL1區間。胃蛋白酶消化處理之小型膠原蛋白,於 未還原狀態,經10% SDS/Bis-Tris之聚丙烯醯胺膠體與MES緩 衝液電泳分析,再將蛋白質以考瑪斯藍呈色。結果如第6圖所 示,第1及4欄為未處理之重組小型膠原蛋白XXI,分別為 mC21AP4H以及mC21/P4H。胃蛋白酶以箭頭表示。(aCOLl)3 0648-A20623TWF(N2);P13930006; chiumeow 24 1304442 «The decylamine colloid and MES buffer were subjected to electrophoresis analysis under reduced conditions. The protein staining bands were stained with Simple Blue Safestain reagent, trypsin for colloidal enzyme treatment, and analyzed by MALDI-TOF mass spectrometry. The trypsin-treated fragments of mC21 (mC21/P4H, Figure 5B), which were separately expressed as mC21 (mC21AP4H, Figure 5A) and mC21 (mC21/P4H, Figure 5B), which were co-expressed with stably transfected P4H, were selected. It is speculated that the hydroxyl group of the Y position in the XYG three sequence is hydroxylated and is indicated by a black dot. The results showed that the peptide fragments of Drosophila S2 cells alone or in combination with P4H still had substantially unhydroxylated molecular fragments of molecular weights of 1531.86 and 1583.86, respectively. Based on the molecular weight of the oxygen atom added by each peptide, it was found that the trypsin-digested fragment also had a mono- and di-hydroxylated peptide. In S2 cells stably transfected with P4H, the relative intensity of hydroxylation for unhydroxylated peptide molecules was substantially higher than that of untransfected P4H cells (see Figure 5, comparing A and B), and this result was correlated with small collagen molecules. The results of the analysis of the total amino acid composition were consistent. Example 7 · Triple helix structure of small collagen XXI The collagen triple helix structure is resistant to pepsin degradation. In order to confirm whether the COL1 interval of mC21 is a triple helix structure, purified mC21 expressed alone or in combination with P4H is cultured at 0.5 ° C for 15 minutes at 37 ° C for 15 minutes to reach pH 2.5, followed by pepsin. (25 pg/ml) was digested for 2 hours, and its helical structure stability was tested. If mC21 has a triple helix structure, pepsin should only remove the NC1 interval, resulting in a COL1 interval with two cysteines bounded by COL1/NC1. The small collagen, which was digested by pepsin, was analyzed in an unreduced state by electrophoresis of 10% SDS/Bis-Tris polypropylene guanamine colloid and MES buffer, and then the protein was colored in Coomass blue. The results are shown in Fig. 6. Columns 1 and 4 are untreated recombinant small collagen XXI, which are mC21AP4H and mC21/P4H, respectively. Pepsin is indicated by an arrow. (aCOLl)3 0648-A20623TWF(N2);P13930006; chiumeow 24 1304442 «

為三元體雙硫鍵COL1區間;(ocCOLl)為分離之鏈,係來自三元 體非雙硫鍵COL 1區間。當mC21單獨表現於果蠅細胞 (mC21AP4H)時,胃蛋白酶消化處理後,不論何種環境溫度,完 整的鏈間雙硫鍵二元體以及大部分單體皆消失(第2以及3欄), 代表大部分mC21分子之脯胺酸殘基為未羥化者,故沒有形成 三螺旋結構。相反地,與P4H共同表現之mC21(mC21/P4H)經 胃蛋白酶消化處理後,仍殘留某些來自鏈間雙硫鍵三元體 (cxCOL1)3及單體(aCOLl)之抗胃蛋白酶片段(第5欄)。此外,這 些片段在以胃蛋白酶處理前預熱於37 °C(第6欄)之mC21仍存 在,代表某些在穩定轉染P4H之果蠅細胞表現的mC21分子含 有足量羥化脯胺酸穩定三螺旋結構。這些胃蛋白酶處理結果顯 示使mC21與P4H共同表現於果蠅細胞可形成熱穩定性三螺旋 結構。 胃蛋白酶處理後仍存在有抗胃蛋白酶單體片段(aCOLl)(第 6圖,第5以及6欄)代表這些單體可能源自三螺旋結構之非鏈 間雙硫鍵三元體,其可在SDS-PAGE時被分解為單鏈。為確認 在穩定轉染P4H之果繩S2細胞中共同表現的mC21含有非鍵間 雙硫鍵三元體,採用膠體過濾管柱分離不同的mC21片段。經 純化之在穩定轉染P4H之果蠅S2細胞中共同表現的重組mC21 可由事先經0.1 M NaCl,50 mM乙酸鈉(pH 6·0)平衡過之 Superdex 200(HR 10/30)膠體過濾管柱分離,而不需先經變性處 理(第7A圖之a),也不須先經5 mM DTT熱處理15分鐘(第7A 圖之b)。管柱流速為0.4 ml/分鐘。與P4H共同表現之mc21在 自然環境下沖提可得兩波峰(第7A圖之a)。將不同波峰級分(第 7A圖中編號為1至3)於未還原狀態下以SDS-PAGE分析。膠體 以硝酸銀染色呈色。結果顯示較早之波峰級分(第1波峰)含有鏈 0648-A20623TWF(N2);P13930006; chiumeow 25 1304442 I i 間雙硫鍵三元體,二元體以及非鏈間雙硫鍵單體之混合物,而 較後之波峰級分(第2波峰)僅含有非鏈間雙硫鍵單體(第7B圖, 第1以及2攔)。 較早波峰級分中與鏈間雙硫鍵三元體同時沖提出之單體代 表這些單體係來自非鏈間雙硫鍵三元體。以DTT熱處理後,三 ^ 鏈會分解而沖提於後來之波峰(第7A圖之b,第3波峰),而僅 . 見單體(第7B圖,第3欄)。由上述可知,於果蠅S2細胞系統 中與P4H同時表現之mC21三螺旋結構含有鏈間以及非鏈間雙 硫鍵三元體之混合物。It is a ternary disulfide bond COL1 interval; (ocCOLl) is an isolated chain derived from the ternary non-disulfide bond COL 1 interval. When mC21 is expressed alone in Drosophila cells (mC21AP4H), after the pepsin digestion treatment, the intact interchain disulfide binary and most of the monomers disappear regardless of the ambient temperature (columns 2 and 3). The proline residue representing most of the mC21 molecule is unhydroxylated, so no triple helix structure is formed. Conversely, after pepsin digestion with mC21 (mC21/P4H), which is co-expressed with P4H, some anti-pepsin fragments from interchain disulfide triplet (cxCOL1)3 and monomer (aCOL1) remain. Column 5). In addition, these fragments are still present in mC21 pre-warmed at 37 °C (column 6) prior to treatment with pepsin, representing some of the mC21 molecules that are expressed in Drosophila cells stably transfected with P4H containing sufficient hydroxylated proline Stable triple helix structure. These pepsin treatment results showed that mC21 and P4H together exhibited in Drosophila cells to form a thermostable triple helix structure. An anti-pepsin monomer fragment (aCOL1) is still present after pepsin treatment (Fig. 6, columns 5 and 6), indicating that these monomers may be derived from a non-interchain disulfide triplet of a triple helix structure, which may It is broken down into single strands during SDS-PAGE. In order to confirm that mC21 co-expressed in the fruit transfected S2 cells stably transfected with P4H contained a non-bonded disulfide triplet, a different mC21 fragment was separated by a colloidal filter column. The purified recombinant mC21 expressed in Drosophila S2 cells stably transfected with P4H can be superdex 200 (HR 10/30) colloidal filter tube previously equilibrated with 0.1 M NaCl, 50 mM sodium acetate (pH 6.00). The column is separated without first denaturation (Fig. 7A a) and does not need to be heat treated with 5 mM DTT for 15 minutes (Fig. 7A, b). The column flow rate was 0.4 ml/min. The mc21 exhibited in conjunction with P4H can be extracted in a natural environment to obtain two peaks (Fig. 7A a). Different peak fractions (numbered 1 to 3 in Figure 7A) were analyzed by SDS-PAGE in an unreduced state. The colloid is colored in silver nitrate. The results show that the earlier peak fraction (the first peak) contains the chain 0648-A20623TWF (N2); P13930006; chiumeow 25 1304442 I di-sulfur bond ternary, binary and non-chain disulfide monomer The mixture, while the later peak fraction (second peak) contains only non-interchain disulfide monomer (Fig. 7B, panels 1 and 2). The monomers in the earlier peak fractions that are simultaneously conjugated to the interchain disulfide triplets represent these monosystems from non-chain disulfide triplets. After heat treatment with DTT, the tri-chain will decompose and be eluted to the later peak (b) in Fig. 7A, b, and only the monomer (Fig. 7B, column 3). From the above, it is known that the mC21 triple helix structure which is expressed simultaneously with P4H in the Drosophila S2 cell system contains a mixture of interchain and non-chain disulfide triplets.

雖然本發明已以較佳實施例揭露如上,然其並非用以限定 本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍内, 當可作各種之更動與潤飾,故本發明之保護範圍當視後附之申 請專利範圍所界定者為準。 0648-A20623TWF(N2) ;P 13930006; chiumeow 26 13.04442 * 、 【圖式簡單說明】 第1A以及1B圖顯示帶有穩定轉染P4Hoc以及Ρ4Ηβ表現構 築體之擬尺蠖(第1Α圖)以及果蠅S2細胞(第1Β圖)之可溶性蛋 白質萃取物的西方墨點分析。While the invention has been described above by way of a preferred embodiment, it is not intended to limit the invention, and the invention may be modified and modified without departing from the spirit and scope of the invention. The scope of protection is subject to the definition of the scope of the patent application. 0648-A20623TWF(N2) ;P 13930006; chiumeow 26 13.04442 * , [Simple description of the diagram] Figures 1A and 1B show the pseudo-scales (Fig. 1) and Drosophila S2 with stable transfected P4Hoc and Ρ4Ηβ expression constructs. Western blot analysis of soluble protein extracts from cells (Fig. 1).

第2Α以及2Β圖顯示在果蠅S2細胞中人類脯胺酸4-羥化 酶輔助第XXI型小型膠原蛋白之組合。第2Α圖顯示推定之重 組mC21 —級序列。第2Β圖顯示表現於果蠅S2細胞中之mC2l 分子的西方墨點分析。第1欄為果蠅細胞穩定表現 mC21(mC21AP4H)之培養基;第2及3欄為果蠅細胞同時表現 Ρ4Ηα,Ρ4Ηβ,及mC21(mC21/P4H)之培養基。T為鏈間雙硫鍵 三元體;D為鏈間雙硫鍵二雙元體;Μ為單體。 第3圖顯示果蠅細胞穩定轉染Ρ4Ηα,Ρ4Ηβ,及小型膠原 蛋白XXI基因之蛋白質表現的時程試驗。圖中左邊所列為特定 單株抗體。第1欄為穩定轉染之果蠅S2細胞未經Cu2+誘導。Τ 為鏈間雙硫鍵三元體;D為鏈間雙硫鍵二元體;Μ為單體。 第4圖顯示由穩定轉染果蠅S2細胞中純化之小型膠原蛋 白。第1、3攔為還原狀態下,第2、4欄為未還原狀態下。Τ 為鏈間雙硫鍵三元體;D為鏈間雙硫鍵二元體;Μ為單體。 第5Α以及5Β圖顯示果蠅S2細胞表現之小型膠原蛋白經 胰蛋白酶處理之片段的MALDI-TOF質譜分析結果。第5 Α圖為 果蠅S2細胞單獨表現mC21(mC21AP4H),第5B圖為與穩定轉 染之P4H共同表現之mC21(mC21/P4H)的胰蛋白酶處理片段。 推測XYG三序列上Y位置的脯胺酸殘基有羥化者以黑點標示。 第6圖顯示小型膠原蛋白XXI三螺旋結構之特性。第1及 4欄為未處理之重組小型膠原蛋白XXI,分別為mC21AP4H以 及mC21/P4H。胃蛋白酶以箭頭表示。(aCOLl)3為三元體雙硫 0648-A20623TWF(N2);P13930006; chiumeow 27 13.04442 鍵COL1區間;(aCOLl)為分離之鏈,係來自三元體非雙硫鍵 COL 1區間。 第7A以及7B圖顯示以膠體過濾管柱分離小型膠原蛋白 XXI。第7A圖為純化之果蠅S2細胞中與P4H共同表現的重組 mC21。A為未經變性處理者,b為經5 mM DTT (dithiothreitol) ' 加熱15分鐘處理者。第7B圖為不同波峰級分(於第7A圖編號 . 為1至3)在未還原狀態之SDS-PAGE分析結果。T為鏈間雙琉 鍵三元體;D為鏈間雙硫鍵二元體;Μ為單體。Figures 2 and 2 show the combination of human proline 4-hydroxylase-assisted type XXI small collagen in Drosophila S2 cells. Figure 2 shows the putative recombination mC21-level sequence. Figure 2 shows Western blot analysis of mC2l molecules expressed in Drosophila S2 cells. The first column is the medium for the stable expression of mC21 (mC21AP4H) in Drosophila cells; the second and third columns are the cells of Drosophila cells which simultaneously express Ρ4Ηα, Ρ4Ηβ, and mC21 (mC21/P4H). T is an interchain disulfide bond ternary; D is an interchain disulfide double dimer; Μ is a monomer. Figure 3 shows a time course test of protein expression of Drosophila cells stably transfected with Ρ4Ηα, Ρ4Ηβ, and small collagen XXI genes. Specific monoclonal antibodies are listed on the left side of the figure. In column 1, the stably transfected Drosophila S2 cells were not induced by Cu2+. Τ is an interchain disulfide bond ternary; D is an interchain disulfide bond binary; Μ is a monomer. Figure 4 shows a small collagen protein purified from stably transfected Drosophila S2 cells. When the first and third blocks are in the restored state, the second and fourth columns are in the unreduced state. Τ is an interchain disulfide bond ternary; D is an interchain disulfide bond binary; Μ is a monomer. Figures 5 and 5 show the results of MALDI-TOF mass spectrometry analysis of trypsin-treated fragments of small collagen expressed by Drosophila S2 cells. Figure 5 shows that Drosophila S2 cells express mC21 (mC21AP4H) alone, and Figure 5B shows trypsin-treated fragments of mC21 (mC21/P4H) co-expressed with stably transfected P4H. It is speculated that the hydroxyl group at the Y position on the XYG three sequence is hydroxylated and is indicated by a black dot. Figure 6 shows the characteristics of the small collagen XXI triple helix. Columns 1 and 4 are untreated recombinant small collagen XXI, mC21AP4H and mC21/P4H, respectively. Pepsin is indicated by an arrow. (aCOLl) 3 is a ternary disulfide 0648-A20623TWF (N2); P13930006; chiumeow 27 13.04442 bond COL1 interval; (aCOLl) is a separated chain derived from the ternary non-disulfide bond COL 1 interval. Figures 7A and 7B show the separation of small collagen XXI by a colloidal filter column. Figure 7A shows recombinant mC21 co-expressed with P4H in purified Drosophila S2 cells. A is undenatured and b is treated with 5 mM DTT (dithiothreitol) 'heated for 15 minutes. Figure 7B shows the results of SDS-PAGE analysis in the unreduced state for different peak fractions (numbered from Figure 7A. 1 to 3). T is a chain double bismuth bond ternary body; D is an interchain disulfide bond binary body; Μ is a monomer.

【主要元件符號說明】 無0[Main component symbol description] No 0

0648-A20623TWF(N2);P13930006; chiumeow 28 >1304442 / 《日修正本 . 序列表 <110>工業技術研究院 <120>生產膠原蛋白之表現系統 <140> <141> <160> 10<140&gt 160> 10

<210> 1 <211> 492 <212> DNA <213>人工序列 <220> <221> CDS <222> 1-492 <223>重組mC21(XXI)核苷酸序列 <400〉 1 atgaagttat gcatattact ggccgtcgtg gcctttgttg gcctctcgct 50 cgggagatct attcctgggc cacctggtcc gataggccca gagggtccca 100 gaggattacc tggtttgcca ggaagagatg gtgttcctgg attagtgggt 150 gtccctggac gtccaggtgt cagaggatta aaaggcctac caggaagaaa 200 tggggaaaaa gggagccaag ggtttgggta tcctggagaa caaggtcctc 250 ctggtccccc aggtccagag ggccctcctg gaataagcaa agaaggtcct 300 ccaggagacc caggtctccc tggcaaagat ggagaccatg gaaaacctgg 350 1304442<210> 1 <211> 492 <212> DNA <213>Artificial sequence <220><221> CDS <222> 1-492 <223> Recombinant mC21 (XXI) nucleotide sequence < 400> 1 atgaagttat gcatattact ggccgtcgtg gcctttgttg gcctctcgct 50 cgggagatct attcctgggc cacctggtcc gataggccca gagggtccca 100 gaggattacc tggtttgcca ggaagagatg gtgttcctgg attagtgggt 150 gtccctggac gtccaggtgt cagaggatta aaaggcctac caggaagaaa 200 tggggaaaaa gggagccaag ggtttgggta tcctggagaa caaggtcctc 250 ctggtccccc aggtccagag ggccctcctg gaataagcaa agaaggtcct 300 ccaggagacc caggtctccc tggcaaagat ggagaccatg gaaaacctgg 350 1304442

t A s - aatccaaggg caaccaggcc ccccaggcat ctgcgaccca tcactatgtt 400 ttagtgtaat tgccagaaga gatccgttca gaaaaggacc aaactatagt 450 ctagacgaca gcagccatca tcaccatcac catagcagcg gc 492 <210> 2 <211>t A s - aatccaaggg caaccaggcc ccccaggcat ctgcgaccca tcactatgtt 400 ttagtgtaat tgccagaaga gatccgttca gaaaaggacc aaactatagt 450 ctagacgaca gcagccatca tcaccatcac catagcagcg gc 492 <210> 2 <211>

<212> PRT <213>人工序列 <220> <221> PEPTIDE <222> 1-164 <223>重組mC21(XXI)胺基酸序列 <400> 2<212> PRT <213> Artificial sequence <220><221> PEPTIDE <222> 1-164 <223> Recombinant mC21 (XXI) amino acid sequence <400>

Met Lys Leu Cys lie Leu Leu Ala Val Val 10 Ala Phe Val Gly Leu Ser Leu Gly Arg Ser 20 lie Pro Gly Pro Pro Gly Pro lie Gly Pro 30 Glu Gly Pro Arg Gly Leu Pro Gly Leu Pro 40 Gly Arg Asp Gly Val Pro Gly Leu Val Gly 50 Val Pro Gly Arg Pro Gly Val Arg Gly Leu 60 Lys Gly Leu Pro Gly Arg Asn Gly Glu Lys 70 Gly Ser Gin Gly Phe Gly Tyr Pro Gly Glu 80 Gin Gly Pro Pro Gly Pro Pro Gly Pro Glu 90Met Lys Leu Cys lie Leu Leu Ala Val Val 10 Ala Phe Val Gly Leu Ser Leu Gly Arg Ser 20 lie Pro Gly Pro Pro Gly Pro lie Gly Pro 30 Glu Gly Pro Arg Gly Leu Pro Gly Leu Pro 40 Gly Arg Asp Gly Val Pro Gly Leu Val Gly 50 Val Pro Gly Arg Pro Gly Val Arg Gly Leu 60 Lys Gly Leu Pro Gly Arg Asn Gly Glu Lys 70 Gly Ser Gin Gly Gly Gly Tyr Pro Gly Glu 80 Gin Gly Pro Pro Gly Pro Pro Gly Pro Glu 90

Gly Pro Pro Gly lie Ser Lys Glu Gly Pro 100 1304442 164Gly Pro Pro Gly lie Ser Lys Glu Gly Pro 100 1304442 164

Pro Gly Asp Pro Gly Leu Pro Gly Lys Asp 110 Gly Asp His Gly Lys Pro Gly lie Gin Gly 120 Gin Pro Gly Pro Pro Gly lie Cys Asp Pro 130 Ser Leu Cys Phe Ser Val lie Ala Arg Arg 140 Asp Pro Phe Arg Lys Gly Pro Asn Tyr Ser 150 Leu Asp Gly Ser Ser His His His His His 160 His Ser Ser GlyPro Gly Asp Pro Gly Leu Pro Gly Lys Asp 110 Gly Asp His Gly Lys Pro Gly lie Gin Gly 120 Gin Pro Gly Pro Pro Gly lie Cys Asp Pro 130 Ser Leu Cys Phe Ser Val lie Ala Arg Arg 140 Asp Pro Phe Arg Lys Gly Pro Asn Tyr Ser 150 Leu Asp Gly Ser Ser His His His His His 160 His Ser Ser Gly

<210> 3 <211> 1602 <212> DNA <213> homo sapien <220> <221>基因 <222> 1-1602 <223>人類脯胺酸4-羥化酶α次單位 <400> 3 atggtctggt atatattaat tataggaatt ctgcttcccc agtctttggc 50 tcatccaggc ttttttactt caattggtca gatgactgat ttgatccata 100 ctgagaaaga tctggtgact tctctgaaag attatattaa ggcagaagag 150 gacaagttag aacaaataaa aaaatgggca gagaagttag atcggctaac 200 tagtacagcg acaaaagatc cagaaggatt tgttgggcat ccagtaaatg 250 cattcaaatt aatgaaacgt ctgaatactg agtggagtga gttggagaat 300 1304442<210> 3 <211> 1602 <212> DNA <213> homo sapien <220><221> gene <222> 1-1602 <223> Human proline 4-hydroxylase α subunit < 400 > 3 atggtctggt atatattaat tataggaatt ctgcttcccc agtctttggc 50 tcatccaggc ttttttactt caattggtca gatgactgat ttgatccata 100 ctgagaaaga tctggtgact tctctgaaag attatattaa ggcagaagag 150 gacaagttag aacaaataaa aaaatgggca gagaagttag atcggctaac tagtacagcg acaaaagatc cagaaggatt tgttgggcat ccagtaaatg 250 cattcaaatt aatgaaacgt ctgaatactg agtggagtga 200 gttggagaat 300 1304442

ctggtcctta aggatatgtc agatggcttt atctctaacc taaccattca 350 gagaccagta ctttctaatg atgaagatca ggttggggca gccaaagctc 400 tgttacgtct ccaggatacc tacaatttgg atacagatac catctcaaag 450 ggtaatcttc caggagtgaa acacaaatct tttctaacgg ctgaggactg 500 ctttgagttg ggcaaagtgg cctatacaga agcagattat taccatacgg 550 aactgtggat ggaacaagcc ctaaggcaac tggatgaagg cgagatttct 600 accatagata aagtctctgt tctagattat ttgagctatg cggtatatca 650 gcagggagac ctggataagg cacttttgct cacaaagaag cttcttgaac 700 tagatcctga acatcagagg gctaatggta acttaaaata ttttgagtat 750 ataatggcta aagaaaaaga tgtcaataag tctgcttcag atgaccaatc 800 tgatcagaaa actacaccaa agaaaaaagg ggttgctgtg gattacctgc 850 cagagagaca gaagtacgaa atgctgtgcc gtggggaggg tatcaaaatg 900 acccctcgga gacagaaaaa actcttttgc cgctgccatg atggaaaccg 950 taatcctaaa tttattctgg ctccagctaa acaggaggat gaatgggaca 1000 agcctcgtat tattcgcttc catgatatta tttctgatgc agaaattgaa 1050 atcgtcaaag acctagcaaa accaaggctg aggcgagcca ccatttcaaa 1100 cccaatagca ggagacttgg agacggtaca ttacagaatt agcaaaagtg 1150 cctggctctc tggctatgaa aatcctgtgg tgtctcgaat taatatgaga 1200 atacaagatc taacaggact agatgtttcc acagcagagg aattacaggt 1250 agcaaattat ggagttggag gacagtatga accccatttt gactttgcac 1300 ggaaagatga gccagatgct ttcaaagagc tggggacagg aaatagaatt 1350 gctacatggc tgttttatat gagtgatgtg tctgcaggag gagccactgt 1400 ttttcctgaa gttggagcta gtgtttggcc caaaaaagga actgctgttt 1450 1304442 f. 摩 . tctggtataa tctgtttgcc agtggagaag gagattatag tacacggcat 1500 gcagcctgtc cagtgctagt tggcaacaaa tgggtatcca ataaatggct 1550 ccatgaacgt ggacaagaat ttcgaagacc ttgtacgttg tcagaattgg 1600 aa 1602ctggtcctta aggatatgtc agatggcttt atctctaacc taaccattca 350 gagaccagta ctttctaatg atgaagatca ggttggggca gccaaagctc 400 tgttacgtct ccaggatacc tacaatttgg atacagatac catctcaaag 450 ggtaatcttc caggagtgaa acacaaatct tttctaacgg ctgaggactg 500 ctttgagttg ggcaaagtgg cctatacaga agcagattat taccatacgg 550 aactgtggat ggaacaagcc ctaaggcaac tggatgaagg cgagatttct 600 accatagata aagtctctgt tctagattat ttgagctatg cggtatatca 650 gcagggagac ctggataagg cacttttgct cacaaagaag cttcttgaac 700 tagatcctga acatcagagg gctaatggta acttaaaata ttttgagtat 750 ataatggcta aagaaaaaga tgtcaataag tctgcttcag atgaccaatc 800 tgatcagaaa actacaccaa agaaaaaagg ggttgctgtg gattacctgc 850 cagagagaca gaagtacgaa atgctgtgcc gtggggaggg tatcaaaatg 900 acccctcgga gacagaaaaa actcttttgc cgctgccatg atggaaaccg 950 taatcctaaa tttattctgg ctccagctaa acaggaggat gaatgggaca 1000 agcctcgtat tattcgcttc catgatatta tttctgatgc agaaattgaa 1050 atcgtcaaag acctagcaaa accaaggctg aggcgagcca ccatttcaaa 1100 cccaatagca ggagacttgg agacggtaca ttacagaatt Agcaaaagt g 1150 cctggctctc tggctatgaa aatcctgtgg tgtctcgaat taatatgaga 1200 atacaagatc taacaggact agatgtttcc acagcagagg aattacaggt 1250 agcaaattat ggagttggag gacagtatga accccatttt gactttgcac 1300 ggaaagatga gccagatgct ttcaaagagc tggggacagg aaatagaatt 1350 gctacatggc tgttttatat gagtgatgtg tctgcaggag gagccactgt 1400 ttttcctgaa gttggagcta gtgtttggcc caaaaaagga actgctgttt 1450 1304442 f. mol. tctggtataa tctgtttgcc agtggagaag gagattatag tacacggcat 1500 gcagcctgtc Cagtgctagt tggcaacaaa tgggtatcca ataaatggct 1550 ccatgaacgt ggacaagaat ttcgaagacc ttgtacgttg tcagaattgg 1600 aa 1602

<210> 4 <211> 534 <212> PRT <213> homo sapien <220> <221>基因 <222> 1-534 <223>人類脯胺酸4-羥化酶α次單位 <400> 4<210> 4 <211> 534 <212> PRT <213> homo sapien <220><221> gene <222> 1-534 <223> Human proline 4-hydroxylase次次单位<400> 4

Met Val Trp Tyr lie Leu lie lie Gly lie 10 Leu Leu Pro Gin Ser Leu Ala His Pro Gly 20 Phe Phe Thr Ser lie Gly Gin Met Thr Asp 30 Leu lie His Thr Glu Lys Asp Leu Val Thr 40 Ser Leu Lys Asp Tyr lie Lys Ala Glu Glu 50 Asp Lys Leu Glu Gin lie Lys Lys Trp Ala 60 Glu Lys Leu Asp Arg Leu Thr Ser Thr Ala 70 Thr Lys Asp Pro Glu Gly Phe Val Gly His 80 Pro Val Asn Ala Phe Lys Leu Met Lys Arg 90 1304442Met Val Trp Tyr lie Leu lie lie Gly lie 10 Leu Leu Pro Gin Ser Leu Ala His Pro Gly 20 Phe Phe Thr Ser lie Gly Gin Met Thr Asp 30 Leu lie His Thr Glu Lys Asp Leu Val Thr 40 Ser Leu Lys Asp Tyr lie Lys Ala Glu Glu 50 Asp Lys Leu Glu Gin lie Lys Lys Trp Ala 60 Glu Lys Leu Asp Arg Leu Thr Ser Thr Ala 70 Thr Lys Asp Pro Glu Gly Phe Val Gly His 80 Pro Val Asn Ala Phe Lys Leu Met Lys Arg 90 1304442

Leu Asn Thr Glu Trp Ser Glu Leu Glu Asn 100 Leu Val Leu Lys Asp Met Ser Asp Gly Phe 110 lie Ser Asn Leu Thr lie Gin Arg Pro Val 120 Leu Ser Asn Asp Glu Asp Gin Val Gly Ala 130 Ala Lys Ala Leu Leu Arg Leu Gin Asp Thr 140 Tyr Asn Leu Asp Thr Asp Thr lie Ser Lys 150 Gly Asn Leu Pro Gly Val Lys His Lys Ser 160 Phe Leu Thr Ala Glu Asp Cys Phe Glu Leu 170 Gly Lys Val Ala Tyr Thr Glu Ala Asp Tyr 180 Tyr His Thr Glu Leu Trp Met Glu Gin Ala 190 Leu Arg Gin Leu Asp Glu Gly Glu lie Ser 200 Thr lie Asp Lys Val Ser Val Leu Asp Tyr 210 Leu Ser Tyr Ala Val Tyr Gin Gin Gly Asp 220 Leu Asp Lys Ala Leu Leu Leu Thr Lys Lys 230 Leu Leu Glu Leu Asp Pro Glu His Gin Arg 240 Ala Asn Gly Asn Leu Lys Tyr Phe Glu Tyr 250 lie Met Ala Lys Glu Lys Asp Val Asn Lys 260 Ser Ala Ser Asp Asp Gin Ser Asp Gin Lys 270 Thr Thr Pro Lys Lys Lys Gly Val Ala Val 280 Asp Tyr Leu Pro Glu Arg Gin Lys Tyr Glu 290 Met Leu Cys Arg Gly Glu Gly He Lys Met 300 Thr Pro Arg Arg Gin Lys Lys Leu Phe Cys 310 Arg Cys His Asp Gly Asn Arg Asn Pro Lys 320Leu Asn Thr Glu Trp Ser Glu Leu Glu Asn 100 Leu Val Leu Lys Asp Met Ser Asp Gly Phe 110 lie Ser Asn Leu Thr lie Gin Arg Pro Val 120 Leu Ser Asn Asp Glu Asp Gin Val Gly Ala 130 Ala Lys Ala Leu Leu Arg Leu Gin Asp Thr 140 Tyr Asn Leu Asp Thr Asp Thr lie Ser Lys 150 Gly Asn Leu Pro Gly Val Lys His Lys Ser 160 Phe Leu Thr Ala Glu Asp Cys Phe Glu Leu 170 Gly Lys Val Ala Tyr Thr Glu Ala Asp Tyr 180 Tyr His Thr Glu Leu Trp Met Glu Gin Ala 190 Leu Arg Gin Leu Asp Glu Gly Glu lie Ser 200 Thr lie Asp Lys Val Ser Val Leu Asp Tyr 210 Leu Ser Tyr Ala Val Tyr Gin Gin Gly Asp 220 Leu Asp Lys Ala Leu Leu Leu Thr Lys Lys 230 Leu Leu Glu Leu Asp Pro Glu His Gin Arg 240 Ala Asn Gly Asn Leu Lys Tyr Phe Glu Tyr 250 lie Met Ala Lys Glu Lys Asp Val Asn Lys 260 Ser Ala Ser Asp Asp Gin Ser Asp Gin Lys 270 Thr Thr Pro Lys Lys Lys Gly Val Ala Val 280 Asp Tyr Leu Pro Glu Arg Gin Lys Tyr Glu 290 Met Leu Cys Arg Gly Glu Gly He Lys Met 300 Thr Pro Arg Arg Gin Lys Lys Leu Phe Cys 310 Arg Cys His Asp Gly Asn Arg Asn P Ro Lys 320

13044421304442

Phe lie Leu Ala Pro Ala Lys Gin Glu Asp 330 Glu Trp Asp Lys Pro Arg lie lie Arg Phe 340 His Asp lie lie Ser Asp Ala Glu lie Glu 350 lie Val Lys Asp Leu Ala Lys Pro Arg Leu 360 Arg Arg Ala Thr lie Ser Asn Pro lie Ala 370 Gly Asp Leu Glu Thr Val His Tyr Arg lie 380 Ser Lys Ser Ala Trp Leu Ser Gly Tyr Glu 390 Asn Pro Val Val Ser Arg lie Asn Met Arg 400 lie Gin Asp Leu Thr Gly Leu Asp Val Ser 410 Thr Ala Glu Glu Leu Gin Val Ala Asn Tyr 420 Gly Val Gly Gly Gin Tyr Glu Pro His Phe 430 Asp Phe Ala Arg Lys Asp Glu Pro Asp Ala 440 Phe Lys Glu Leu Gly Thr Gly Asn Arg lie 450 Ala Thr Trp Leu Phe Tyr Met Ser Asp Val 460 Ser Ala Gly Gly Ala Thr Val Phe Pro Glu 470 Val Gly Ala Ser Val Trp Pro Lys Lys Gly 480 Thr Ala Val Phe Trp Tyr Asn Leu Phe Ala 490 Ser Gly Glu Gly Asp Tyr Ser Thr Arg His 500 Ala Ala Cys Pro Val Leu Val Gly Asn Lys 510 Trp Val Ser Asn Lys Trp Leu His Glu Arg 520 Gly Gin Glu Phe Arg Arg Pro Cys Thr Leu 530Phe lie Leu Ala Pro Ala Lys Gin Glu Asp 330 Glu Trp Asp Lys Pro Arg lie lie Arg Phe 340 His Asp lie lie Ser Asp Ala Glu lie Glu 350 lie Val Lys Asp Leu Ala Lys Pro Arg Leu 360 Arg Arg Ala Thr lie Ser Asn Pro lie Ala 370 Gly Asp Leu Glu Thr Val His Tyr Arg lie 380 Ser Lys Ser Ala Trp Leu Ser Gly Tyr Glu 390 Asn Pro Val Val Ser Arg lie Asn Met Arg 400 lie Gin Asp Leu Thr Gly Leu Asp Val Ser 410 Thr Ala Glu Glu Leu Gin Val Ala Asn Tyr 420 Gly Val Gly Gly Gin Tyr Glu Pro His Phe 430 Asp Phe Ala Arg Lys Asp Glu Pro Asp Ala 440 Phe Lys Glu Leu Gly Thr Gly Asn Arg lie 450 Ala Thr Trp Leu Phe Tyr Met Ser Asp Val 460 Ser Ala Gly Gly Ala Thr Val Phe Pro Glu 470 Val Gly Ala Ser Val Trp Pro Lys Lys Gly 480 Thr Ala Val Phe Trp Tyr Asn Leu Phe Ala 490 Ser Gly Glu Gly Asp Tyr Ser Thr Arg His 500 Ala Ala Cys Pro Val Leu Val Gly Asn Lys 510 Trp Val Ser Asn Lys Trp Leu His Glu Arg 520 Gly Gin Glu Phe Arg Arg Pro Cys Thr Leu 530

Ser Glu Leu Glu 1304442 <210> 5 <211> 1524 <212> DNA <213> homo sapien <220> <221>基因 <222> 1-1524Ser Glu Leu Glu 1304442 <210> 5 <211> 1524 <212> DNA <213> homo sapien <220><221> gene <222>

<223>人類脯胺酸4-羥化酶β次單位 <400>·5 atggtgcgcc gcgctctgct gtgcctgccg tggaccgccc tggtgcgcgc 50 cgacgccccc gaggaggagg accacgtcct ggtgctgegg aaaagcaact 100 tcgcggaggc gctggcggcc cacaagtacc tgctggtgga gttctatgcc 150 ccttggtgtg gccactgcaa ggctctggcc cctgagtatg ccaaagccgc 200 tgggaagctg aaggcagaag gttccgagat caggttggcc aaggtggacg 250 ccacggagga gtctgaccta gcccagcagt acggcgtgcg cggctatccc 300 accatcaagt tcttcaggaa tggagacacg gcttccccca aggaatatac 350 agctggcaga gaggctgatg acatcgtgaa ctggctgaag aagcgcacgg 400 gcccggctgc caccaccctg cctgacggcg cagctgcaga gtccttggtg 450 gagtccagcg aggtggctgt catcggcttc ttcaaggacg tggagtcgga 500 ctctgccaag cagtttttgc aggcagcaga ggccatcgat gacataccat 550 ttgggatcac ttccaacagt gacgtgttct ccaaatacca gctcgacaaa 600 gatggggttg tcctctttaa gaagtttgat gaaggccgga acaactttga 650 aggggaggtc accaaggaga acctgctgga ctttatcaaa cacaaccagc 700 1304442≪ 223 > human-proline-4-hydroxylase β subunit < 400 > · 5 atggtgcgcc gcgctctgct gtgcctgccg tggaccgccc tggtgcgcgc 50 cgacgccccc gaggaggagg accacgtcct ggtgctgegg aaaagcaact 100 tcgcggaggc gctggcggcc cacaagtacc tgctggtgga gttctatgcc 150 ccttggtgtg gccactgcaa ggctctggcc cctgagtatg ccaaagccgc 200 tgggaagctg aaggcagaag gttccgagat caggttggcc aaggtggacg 250 ccacggagga gtctgaccta gcccagcagt acggcgtgcg cggctatccc 300 accatcaagt tcttcaggaa tggagacacg gcttccccca aggaatatac 350 agctggcaga gaggctgatg acatcgtgaa ctggctgaag aagcgcacgg 400 gcccggctgc caccaccctg cctgacggcg cagctgcaga gtccttggtg 450 gagtccagcg aggtggctgt catcggcttc ttcaaggacg tggagtcgga 500 ctctgccaag cagtttttgc aggcagcaga ggccatcgat gacataccat 550 ttgggatcac ttccaacagt gacgtgttct ccaaatacca gctcgacaaa 600 gatggggttg tcctctttaa gaagtttgat gaaggccgga acaactttga 650 Aggggaggtc accaaggaga acctgctgga ctttatcaaa cacaaccagc 700 1304442

tgccccttgt catcgagttc accgagcaga cagccccgaa gatttttgga 750 ggtgaaatca agactcacat cctgctgttc ttgcccaaga gtgtgtctga 800 ctatgacggc aaactgagca acttcaaaac agcagccgag agcttcaagg 850 gcaagatcct gttcatcttc atcgacagcg accacaccga caaccagcgc 900 atcctcgagt tctttggcct gaagaaggaa gagtgcccgg ccgtgcgcct 950 catcaccctg gaggaggaga tgaccaagta caagcccgaa tcggaggagc 1000 tgacggcaga gaggatcaca gagttctgcc accgcttcct ggagggcaaa 1050 atcaagcccc acctgatgag ccaggagctg ccggaggact gggacaagca 1100 gcctgtcaag gtgcttgttg ggaagaactt tgaagacgtg gcttttgatg 1150 aaaaaaaaaa cgtctttgtg gagttctatg ccccatggtg tggtcactgc 1200 aaacagttgg ctcccatttg ggataaactg ggagagacgt acaaggacca 1250 tgagaacatc gtcatcgcca agatggactc gactgccaac gaggtggagg 1300 ccgtcaaagt gcacagcttc cccacactca agttctttcc tgccagtgcc 1350 gacaggacgg tcattgatta caacggggaa cgcacgctgg atggttttaa 1400 gaaattcctg gagagcggtg gccaagatgg ggcagggggt gatgacgatc 1450 tcgaggacct ggaagaagca gaggagccag acatggagga agacgatgat 1500 cagaaagctg tgaaagatga actg <210> 6 <211> 508 <212> PRT <213> homo sapien 9 <220> 1304442 <221>基因 <222> 1-508 <223>人類脯胺酸4-羥化酶β次單位 <400〉 6tgccccttgt catcgagttc accgagcaga cagccccgaa gatttttgga 750 ggtgaaatca agactcacat cctgctgttc ttgcccaaga gtgtgtctga 800 ctatgacggc aaactgagca acttcaaaac agcagccgag agcttcaagg 850 gcaagatcct gttcatcttc atcgacagcg accacaccga caaccagcgc 900 atcctcgagt tctttggcct gaagaaggaa gagtgcccgg ccgtgcgcct 950 catcaccctg gaggaggaga tgaccaagta caagcccgaa tcggaggagc 1000 tgacggcaga gaggatcaca gagttctgcc accgcttcct ggagggcaaa 1050 atcaagcccc acctgatgag ccaggagctg ccggaggact gggacaagca 1100 gcctgtcaag gtgcttgttg ggaagaactt tgaagacgtg gcttttgatg 1150 aaaaaaaaaa cgtctttgtg gagttctatg ccccatggtg tggtcactgc 1200 aaacagttgg ctcccatttg ggataaactg ggagagacgt acaaggacca 1250 tgagaacatc gtcatcgcca agatggactc gactgccaac gaggtggagg 1300 ccgtcaaagt gcacagcttc cccacactca agttctttcc tgccagtgcc 1350 gacaggacgg tcattgatta caacggggaa cgcacgctgg atggttttaa 1400 gaaattcctg gagagcggtg gccaagatgg ggcagggggt gatgacgatc 1450 tcgaggacct ggaagaagca gaggagccag acatggagga agacgatgat 1500 cagaaagctg tgaaagatga actg <210> 6 < 211 > 508 <212> PRT <213> homo sapien 9 <220> 1304442 <221>gene <222> 1-508 <223> Human proline 4-hydroxylase beta subunit < 400> 6

Met Val Arg Arg Ala Leu Leu Cys Leu Pro 50 Trp Thr Ala Leu Val Arg Ala Asp Ala Pro 100 Glu Glu Glu Asp His Val Leu Val Leu Arg 150 Lys Ser Asn Phe Ala Glu Ala Leu Ala Ala 200 His Lys Tyr Leu Leu Val Glu Phe Tyr Ala 250 Pro Trp Cys Gly His Cys Lys Ala Leu Ala 300 Pro Glu Tyr Ala Lys Ala Ala Gly Lys Leu 350 Lys Ala Glu Gly Ser Glu lie Arg Leu Ala 400 Lys Val Asp Ala Thr Glu Glu Ser Asp Leu 450 Ala Gin Gin Tyr Gly Val Arg Gly Tyr Pro 500 Thr lie Lys Phe Phe Arg Asn Gly Asp Thr 550 Ala Ser Pro Lys Glu Tyr Thr Ala Gly Arg 600 Glu Ala Asp Asp lie Val Asn Trp Leu Lys 650 Lys Arg Thr Gly Pro Ala Ala Thr Thr Leu 700 Pro Asp Gly Ala Ala Ala Glu Ser Leu Val 750 Glu Ser Ser Glu Val Ala Val lie Gly Phe 800 Phe Lys Asp Val Glu Ser Asp Ser Ala Lys 850 Gin Phe Leu Gin Ala Ala Glu Ala lie Asp 900 Asp lie Pro Phe Gly lie Thr Ser Asn Ser 950 10 1304442Met Val Arg Arg Ala Leu Leu Cys Leu Pro 50 Trp Thr Ala Leu Val Arg Ala Asp Ala Pro 100 Glu Glu Glu Asp His Val Leu Val Leu Arg 150 Lys Ser Asn Phe Ala Glu Ala Leu Ala Ala 200 His Lys Tyr Leu Leu Val Glu Phe Tyr Ala 250 Pro Trp Cys Gly His Cys Lys Ala Leu Ala 300 Pro Glu Tyr Ala Lys Ala Ala Gly Lys Leu 350 Lys Ala Glu Gly Ser Glu lie Arg Leu Ala 400 Lys Val Asp Ala Thr Glu Glu Ser Asp Leu 450 Ala Gin Gin Tyr Gly Val Arg Gly Tyr Pro 500 Thr lie Lys Phe Phe Arg Asn Gly Asp Thr 550 Ala Ser Pro Lys Glu Tyr Thr Ala Gly Arg 600 Glu Ala Asp Asp lie Val Asn Trp Leu Lys 650 Lys Arg Thr Gly Pro Ala Ala Thr Thr Leu 700 Pro Asp Gly Ala Ala Ala Glu Ser Leu Val 750 Glu Ser Ser Glu Val Ala Val lie Gly Phe 800 Phe Lys Asp Val Glu Ser Asp Ser Ala Lys 850 Gin Phe Leu Gin Ala Ala Glu Ala lie Asp 900 Asp lie Pro Phe Gly lie Thr Ser Asn Ser 950 10 1304442

Asp Val Phe Ser Lys Tyr Gin Leu Asp Lys 1000 Asp Gly Val Val Leu Phe Lys Lys Phe Asp 1050 Glu Gly Arg Asn Asn Phe Glu Gly Glu Val 1100 Thr Lys Glu Asn Leu Leu Asp Phe lie Lys 1150 His Asn Gin Leu Pro Leu Val lie Glu Phe 1200 Thr Glu Gin Thr Ala Pro Lys lie Phe Gly 1250 Gly Glu lie Lys Thr His lie Leu Leu Phe 1300 Leu Pro Lys Ser Val Ser Asp Tyr Asp Gly 1350 Lys Leu Ser Asn Phe Lys Thr Ala Ala Glu 1400 Ser Phe Lys Gly Lys lie Leu Phe lie Phe 1450 lie Asp Ser Asp His Thr Asp Asn Gin Arg 1500 lie Leu Glu Phe Phe Gly Leu Lys Lys Glu 1550 Glu Cys Pro Ala Val Arg Leu lie Thr Leu 1600 Glu Glu Glu Met Thr Lys Tyr Lys Pro Glu 1650 Ser Glu Glu Leu Thr Ala Glu Arg lie Thr 1700 Glu Phe Cys His Arg Phe Leu Glu Gly Lys 1750 lie Lys Pro His Leu Met Ser Gin Glu Leu 1800 Pro Glu Asp Trp Asp Lys Gin Pro Val Lys 1850 Val Leu Val Gly Lys Asn Phe Glu Asp Val 1900 Ala Phe Asp Glu Lys Lys Asn Val Phe Val 1950 Glu Phe Tyr Ala Pro Trp Cys Gly His Cys 2000 Lys Gin Leu Ala Pro lie Trp Asp Lys Leu 2050 Gly Glu Thr Tyr Lys Asp His Glu Asn lie 2100 1304442 Μ ♦ • Val lie Ala Lys Met Asp Ser Thr Ala Asn 2150 %Asp Val Phe Ser Lys Tyr Gin Leu Asp Lys 1000 Asp Gly Val Val Leu Phe Lys Lys Phe Asp 1050 Glu Gly Arg Asn Asn Phe Glu Gly Glu Val 1100 Thr Lys Glu Asn Leu Leu Asp Phe lie Lys 1150 His Asn Gin Leu Pro Leu Val lie Glu Phe 1200 Thr Glu Gin Thr Ala Pro Lys lie Phe Gly 1250 Gly Glu lie Lys Thr His lie Leu Leu Phe 1300 Leu Pro Lys Ser Val Ser Asp Tyr Asp Gly 1350 Lys Leu Ser Asn Phe Lys Thr Ala Ala Glu 1400 Ser Phe Lys Gly Lys lie Leu Phe lie Phe 1450 lie Asp Ser Asp His Thr Asp Asn Gin Arg 1500 lie Leu Glu Phe Phe Gly Leu Lys Lys Glu 1550 Glu Cys Pro Ala Val Arg Leu lie Thr Leu 1600 Glu Glu Glu Met Thr Lys Tyr Lys Pro Glu 1650 Ser Glu Glu Leu Thr Ala Glu Arg lie Thr 1700 Glu Phe Cys His Arg Phe Leu Glu Gly Lys 1750 lie Lys Pro His Leu Met Ser Gin Glu Leu 1800 Pro Glu Asp Trp Asp Lys Gin Pro Val Lys 1850 Val Leu Val Gly Lys Asn Phe Glu Asp Val 1900 Ala Phe Asp Glu Lys Lys Asn Val Phe Val 1950 Glu Phe Tyr Ala Pro Trp Cys Gly His Cys 2000 Lys Gin Leu Ala Pro lie Trp Asp Lys Leu 2050 Gly Glu Th r Tyr Lys Asp His Glu Asn lie 2100 1304442 Μ ♦ • Val lie Ala Lys Met Asp Ser Thr Ala Asn 2150 %

Glu Val Glu Ala Val Lys Val His Ser Phe 2200 Pro Thr Leu Lys Phe Phe Pro Ala Ser Ala 2250 Asp Arg Thr Val lie Asp Tyr Asn Gly Glu 2300 - Arg Thr Leu Asp Gly Phe Lys Lys Phe Leu 2350 Glu Ser Gly Gly Gin Asp Gly Ala Gly Gly 2400 Asp Asp Asp Leu Glu Asp Leu Glu Glu Ala 2450 Glu Glu Pro Asp Met Glu Glu Asp Asp Asp 2500Glu Val Glu Ala Val Lys Val His Ser Phe 2200 Pro Thr Leu Lys Phe Phe Pro Ala Ser Ala 2250 Asp Arg Thr Val lie Asp Tyr Asn Gly Glu 2300 - Arg Thr Leu Asp Gly Phe Lys Lys Phe Leu 2350 Glu Ser Gly Gly Gin Asp Gly Ala Gly Gly 2400 Asp Asp Asp Leu Glu Asp Leu Glu Glu Ala 2450 Glu Glu Pro Asp Met Glu Glu Asp Asp Asp 2500

Gin Lys Ala Val Lys Asp Glu Leu <210> 7 <211> 19 <212> DNA <213>人工序列 <220>Gin Lys Ala Val Lys Asp Glu Leu <210> 7 <211> 19 <212> DNA <213>Artificial Sequence <220>

<222> 1-19 <223>增幅人類脯胺酸4-羥化酶α次單位之正向引子 <400> 7 atcgattatc atgtctgga 19 <210> 8 <211> 19 12 1304442 <212> DNA <213>人工序列 <220> <221> . <222> 1-19 α次單位之反向引子 <223>增幅人類脯胺酸4-羥化酶 <400> 8 ctttgagtga gcatcgatc 19<222> 1-19 <223> Augmentation of human proline 4-hydroxylase alpha subunit positive primer <400> 7 atcgattatc atgtctgga 19 <210> 8 <211> 19 12 1304442 <212> DNA <213>Artificial sequence<220><221>.<222> 1-19 Reverse inversion of α subunits <223> Augmented human proline 4-hydroxylase <400> 8 ctttgagtga gcatcgatc 19

<210> 9 <211> 33 <212> DNA <213>人工序列 <220> <221><210> 9 <211> 33 <212> DNA <213> artificial sequence <220><221>

<222> 1-33 <223>增幅COL21A1之正向引子 <400〉 9 33 ttagatctat tcctgggcca cctggtccga tag<222> 1-33 <223> Increasing the forward index of COL21A1 <400> 9 33 ttagatctat tcctgggcca cctggtccga tag

<210> 10 <211> 30 <212> DNA<210> 10 <211> 30 <212> DNA

< S 13 Ί304442 4 * • <213>人工序列 % <220> <221> <222> 1-30 . <223>增幅COL21A1之反向引子 " <400〉 10 30 aatctagact aatagtttgg tccttttctg<S 13 Ί304442 4 * • <213>Manual sequence % <220><221><222> 1-30 . <223> Increasing COL21A1 reverse introduction "<400> 10 30 aatctagact Aatagtttgg tccttttctg

1414

Claims (1)

I 1304442 第94141441號申請專利範圍修正本 修正日期:97.6.16I 1304442 No. 94141441 Application for Amendment of Patent Scope Amendment Date: 97.6.16 乃年6月¥日修正本 ' 十、申請專利範園: 1·一種重組昆蟲細胞,包括一經轉染之編碼脯胺酸‘羥化 酶之α、β次單位基因、編碼第XXI型膠原蛋白之膠原蛋白三螺 • 旋(C〇Ll·)區間以及C端非膠原蛋白(NC1)區間,其中該編碼脯 . 胺酸‘羥化酶之α次單位係為序列識別號:3之核苷酸序列,該 " 編碼脯胺酸羥化酶之β次單位係為序列識別號:5之核苷酸序 列,該編碼第XXI型膠原蛋白之膠原蛋白三螺旋(c〇L1)區間及 C端非膠原蛋白(NC1)區間係為序列識別號·· i之核苷酸序列。 Φ _2·如申請專利範圍第1項所述之重組昆蟲細胞,其中該細 胞為擬K獲(Trichoplusia ni)細胞。 3 ·如申請專利範圍第1項所述之重組昆蟲細胞,其中該細 胞為朱绳(Drosophila me丨anogaster)細胞。 4·一種生產重組膠原蛋白之方法,其包括以下步驟: ^供一重组昆蟲細胞,其包括一經轉染之編碼脯胺酸4_經 化酶之基因,其中該脯胺酸‘羥化酶基因係為序列識別號:3 以及5之核苷酸序列; • 轉染一表現載體至該細胞,該表現載體包括一重組膠原蛋 白基因,其中該重組膠原蛋白基因係為序列識別號··丨之核苷酸 序列; 於適合該重組膠原蛋白基因表現之條件下培養該細胞;以 及 回收經表現之重組膠原蛋白,其中該經表現之重組膠原蛋 白係經分泌的。 5·如申請專利範圍第4項所述之方法,其中該序列識別號·· 3之核苷酸序列係編碼脯胺酸4-羥化酶之〇^欠單位。 6.如申請專利範圍第4項所述之方法,其中該序列識別號: 4 1304442 5之核苷酸序列係編碼脯胺酸4-羥化酶之β次單位。 > 7·如中請專利範圍第4項所述之方法,人其早中該細胞為擬尺 缓(Trichoplusia ni)細胞。 8. 如申請專利範圍第4項所述之方法,其中該細胞為純 {Drosophila melanogaster)每概 〇 9. 如申請專利範圍第4項所述之方法/其中該重組膠原蛋 白基因係編碼第XXI型膠原蛋白之膠原蛋白三螺旋(c〇L1)區間 以及C端非膠原蛋白(NC1)區間。 10·—種生產重組膠原蛋白之方法’其包括以下步驟: 提供一重組昆蟲細胞,其包括一經轉染之編碼重組膠原蛋 白基因’以及一經轉染之編碼脯胺酸4-經化酶基因,其中該脯 胺酸4-羥化酶基因係為序列識別號:3以及5之核苷酸序列, 且該重組膠原蛋白基因係為序列識別號:i之核苦酸序列; 於適於該重組膠原蛋白表現之條件下培養該重組昆蟲細 胞;以及 回收該經表現之重組膠原蛋白,其中該經表現之重組膠原 蛋白係經分泌的。 11·如申請專利範圍第1〇項所述之方法,其中該細胞為擬 尺緩(Tyichoplusia ni)細胞0 12·如申請專利範圍第10項所述之方法,其中該細胞為果 規(Drosophila melanogaster)細胞。 13·如申請專利範圍第1〇項所述之方法,其中該重組膠原 蛋白基因係編碼第XXI型膠原蛋白之膠原蛋白三螺旋(〇〇]11)區 間以及C端非膠原蛋白(NC1)區間。 14 ·如申請專利範圍第1 〇項所述之方法,其中該序列識別 號:3之核苷酸序列係編碼脯胺酸4-羥化酶之〇^欠單位。 1304442 15.如申請專利範圍第10項所述之方法,其中該序列識別 號:5之核苷酸序列係編碼脯胺酸4-羥化酶之β次單位。The revised version of the June ¥ ¥ Japanese Patent Application: 1. A recombinant insect cell, including a transfected alpha, beta subunit gene encoding a proline-hydroxylase, encoding a type XXI collagen Collagen snail • Cyclone (C〇Ll·) interval and C-terminal non-collagen protein (NC1) interval, wherein the coding 脯. Amino acid 'hydroxylase α subunit is the SEQ ID NO: 3 nucleoside The acid sequence, the "the beta unit of the proline hydroxylase is the nucleotide sequence of the sequence identification number: 5, the collagen triple helix (c〇L1) region encoding the XXI type collagen and C The non-collagen (NC1) region is the nucleotide sequence of the sequence identifier. Φ _2. The recombinant insect cell of claim 1, wherein the cell is a Trichoplusia ni cell. 3. The recombinant insect cell of claim 1, wherein the cell is a Drosophila me丨anogaster cell. 4. A method of producing recombinant collagen, comprising the steps of: providing a recombinant insect cell comprising a transfected gene encoding a proline 4'-enzyme, wherein the proline-hydroxylase gene Is a nucleotide sequence of sequence identification numbers: 3 and 5; • transfecting a expression vector into the cell, the expression vector comprising a recombinant collagen gene, wherein the recombinant collagen gene line is a sequence identifier. a nucleotide sequence; culturing the cell under conditions suitable for expression of the recombinant collagen gene; and recovering the expressed recombinant collagen, wherein the expressed recombinant collagen is secreted. 5. The method of claim 4, wherein the nucleotide sequence of the sequence identifier is encoding a unit of valeric acid 4-hydroxylase. 6. The method of claim 4, wherein the nucleotide sequence of the sequence identification number: 4 1304442 is a beta subunit encoding a proline 4-hydroxylase. > 7. The method of claim 4, wherein the cell is a Trichoplusia ni cell. 8. The method of claim 4, wherein the cell is pure {Drosophila melanogaster, each of which is 9. The method of claim 4, wherein the recombinant collagen gene encoding is XXI Collagen collagen triple helix (c〇L1) interval and C-terminal non-collagen protein (NC1) interval. 10. A method for producing recombinant collagen comprising the steps of: providing a recombinant insect cell comprising a transfected recombinant collagen gene encoding and a transfected methionine-transferase gene; Wherein the proline acid 4-hydroxylase gene sequence is a nucleotide sequence of sequence identification numbers: 3 and 5, and the recombinant collagen gene line is a nucleotide sequence of sequence identification number: i; suitable for the recombination The recombinant insect cells are cultured under conditions in which the collagen is expressed; and the expressed recombinant collagen is recovered, wherein the expressed recombinant collagen is secreted. The method of claim 1, wherein the cell is a Tyichoplusia ni cell. The method of claim 10, wherein the cell is a fruit (Drosophila) Melanogaster) cells. The method of claim 1, wherein the recombinant collagen gene encodes a collagen triple helix (〇〇11) region of type XXI collagen and a C-terminal non-collagen protein (NC1) interval. . 14. The method of claim 1, wherein the nucleotide sequence of the sequence identifier: 3 encodes a unit of valeric acid 4-hydroxylase. The method of claim 10, wherein the nucleotide sequence of the sequence identifier: 5 encodes a beta unit of the proline 4-hydroxylase.
TW94141441A 2005-11-25 2005-11-25 Expression system for producing collagen TWI304442B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW94141441A TWI304442B (en) 2005-11-25 2005-11-25 Expression system for producing collagen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW94141441A TWI304442B (en) 2005-11-25 2005-11-25 Expression system for producing collagen

Publications (1)

Publication Number Publication Date
TWI304442B true TWI304442B (en) 2008-12-21

Family

ID=45070938

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94141441A TWI304442B (en) 2005-11-25 2005-11-25 Expression system for producing collagen

Country Status (1)

Country Link
TW (1) TWI304442B (en)

Similar Documents

Publication Publication Date Title
Bietlot et al. Facile preparation and characterization of the toxin from Bacillus thuringiensis var. kurstaki
US7759090B2 (en) Expression system for producing collagen
ES2401856T3 (en) A method to produce a biologically active polypeptide that has insulinotropic activity
Rinfret et al. The N-terminal cyclophilin-homologous domain of a 150-kilodalton tumor recognition molecule exhibits both peptidylprolyl cis-trans-isomerase and chaperone activities
JPH01104178A (en) Production of enkephalinase, its assay,and pharmaceutical composition containing same
JP2005523001A (en) Materials and methods for preparing dimeric growth factors
TWI304442B (en) Expression system for producing collagen
JPH08333394A (en) Rat obesity gene, its gene product and its production
US8222016B2 (en) Recombinant C-terminal α-amidating enzyme derivative
US7223578B2 (en) Canine COX-1 nucleic acid molecules and fragments thereof
JP5099943B2 (en) Polypeptide, polynucleotide and use thereof
CN104725497B (en) A kind of silkworm mainly assists transport protein BmMFS and its amalgamation and expression and purification process
US20100087005A1 (en) Auxiliary reagent for gene transfer
Bell et al. The N-terminus of PE2 in Sindbis virus-infected cells
NZ232255A (en) Glucagon of high purity and production using a fusion protein
Li et al. Assembly of homotrimeric type XXI minicollagen by coexpression of prolyl 4-hydroxylase in stably transfected Drosophila melanogaster S2 cells
JP5224100B2 (en) Mutant luciferase
KR101099398B1 (en) POLYPEPTIDE CLEAVAGE METHOD USING OmpT PROTEASE VARIANT
WO2003087343A1 (en) Production of stable collagens
JP2004000143A (en) Recombinant fluorescent protein and its complex
JP2864152B2 (en) Functional polypeptide
EP0851930A1 (en) Method for the production of natriuretic peptides through streptavidin-fusion proteins
JP4252299B2 (en) Novel disulfide oxidoreductase and protein activation method using the enzyme
JP2008278761A (en) NEW beta-GALACTOSIDE alpha-2,6-SIALYLTRANSFERASE
Day et al. Eph/Ephrin membrane proteins: a mammalian expression vector pTIg-BOS-Fc allowing rapid protein purification

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees